CN109843380A - The copolymer compositions applied for coating and adhesive - Google Patents
The copolymer compositions applied for coating and adhesive Download PDFInfo
- Publication number
- CN109843380A CN109843380A CN201780064745.6A CN201780064745A CN109843380A CN 109843380 A CN109843380 A CN 109843380A CN 201780064745 A CN201780064745 A CN 201780064745A CN 109843380 A CN109843380 A CN 109843380A
- Authority
- CN
- China
- Prior art keywords
- subscript
- alternatively
- adhesive
- copolymer
- skin contact
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L75/00—Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers
- C08L75/04—Polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0246—Adhesive plasters or dressings characterised by the skin adhering layer
- A61F13/0253—Adhesive plasters or dressings characterised by the skin adhering layer characterized by the adhesive material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/58—Adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
- C08G18/12—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step using two or more compounds having active hydrogen in the first polymerisation step
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/22—Catalysts containing metal compounds
- C08G18/227—Catalysts containing metal compounds of antimony, bismuth or arsenic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/30—Low-molecular-weight compounds
- C08G18/32—Polyhydroxy compounds; Polyamines; Hydroxyamines
- C08G18/3203—Polyhydroxy compounds
- C08G18/3206—Polyhydroxy compounds aliphatic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/48—Polyethers
- C08G18/4833—Polyethers containing oxyethylene units
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/61—Polysiloxanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/72—Polyisocyanates or polyisothiocyanates
- C08G18/74—Polyisocyanates or polyisothiocyanates cyclic
- C08G18/75—Polyisocyanates or polyisothiocyanates cyclic cycloaliphatic
- C08G18/751—Polyisocyanates or polyisothiocyanates cyclic cycloaliphatic containing only one cycloaliphatic ring
- C08G18/752—Polyisocyanates or polyisothiocyanates cyclic cycloaliphatic containing only one cycloaliphatic ring containing at least one isocyanate or isothiocyanate group linked to the cycloaliphatic ring by means of an aliphatic group
- C08G18/753—Polyisocyanates or polyisothiocyanates cyclic cycloaliphatic containing only one cycloaliphatic ring containing at least one isocyanate or isothiocyanate group linked to the cycloaliphatic ring by means of an aliphatic group containing one isocyanate or isothiocyanate group linked to the cycloaliphatic ring by means of an aliphatic group having a primary carbon atom next to the isocyanate or isothiocyanate group
- C08G18/755—Polyisocyanates or polyisothiocyanates cyclic cycloaliphatic containing only one cycloaliphatic ring containing at least one isocyanate or isothiocyanate group linked to the cycloaliphatic ring by means of an aliphatic group containing one isocyanate or isothiocyanate group linked to the cycloaliphatic ring by means of an aliphatic group having a primary carbon atom next to the isocyanate or isothiocyanate group and at least one isocyanate or isothiocyanate group linked to a secondary carbon atom of the cycloaliphatic ring, e.g. isophorone diisocyanate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/72—Polyisocyanates or polyisothiocyanates
- C08G18/74—Polyisocyanates or polyisothiocyanates cyclic
- C08G18/76—Polyisocyanates or polyisothiocyanates cyclic aromatic
- C08G18/7614—Polyisocyanates or polyisothiocyanates cyclic aromatic containing only one aromatic ring
- C08G18/7621—Polyisocyanates or polyisothiocyanates cyclic aromatic containing only one aromatic ring being toluene diisocyanate including isomer mixtures
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L75/00—Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers
- C08L75/04—Polyurethanes
- C08L75/06—Polyurethanes from polyesters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
- C08L83/04—Polysiloxanes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D175/00—Coating compositions based on polyureas or polyurethanes; Coating compositions based on derivatives of such polymers
- C09D175/04—Polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D175/00—Coating compositions based on polyureas or polyurethanes; Coating compositions based on derivatives of such polymers
- C09D175/04—Polyurethanes
- C09D175/06—Polyurethanes from polyesters
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D183/00—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers
- C09D183/04—Polysiloxanes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/40—Additives
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J175/00—Adhesives based on polyureas or polyurethanes; Adhesives based on derivatives of such polymers
- C09J175/04—Polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J175/00—Adhesives based on polyureas or polyurethanes; Adhesives based on derivatives of such polymers
- C09J175/04—Polyurethanes
- C09J175/06—Polyurethanes from polyesters
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J183/00—Adhesives based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Adhesives based on derivatives of such polymers
- C09J183/04—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00655—Plasters adhesive
- A61F2013/00659—Plasters adhesive polymeric base
Abstract
The invention discloses a kind of organic-siloxane copolymer composition, the organic-siloxane copolymer composition can be used for preparing skin contact adhesive or coating.Skin contact adhesive composition include (I) it is organic-siloxane copolymer composition and (II) excipient.Skin contact adhesive by hardening composition preparation can be used for using such as the adhesive of medical adhesive tape, the adhesive for wound dressing, the adhesive for prosthese, ostomy appliance adhesive, for the adhesive of medical monitor tool, for the adhesive of scar therapy treatment, for the adhesive and transdermal drug delivery systems of cosmetics drug paste.Coating composition include (a) it is organic-siloxane copolymer composition and (b) coating additive.The coating by hardening the coating composition preparation can be used for handling leather.
Description
The cross reference of related application
The U.S. Provisional Patent Application Serial No. 62/396336 that patent application claims September in 2016 is submitted on the 19th it is excellent
First weigh.The U.S. Provisional Patent Application of Serial No. 62/396336 is incorporated by reference accordingly.
Background technique
Technical field
Copolymer compositions can be used for preparing skin contact adhesive and/or coating in substrate.It discloses preparation and makes
With the method for copolymer compositions.Copolymer compositions include organosiloxane copolymer.
Brief introduction
Various types of skin contact adhesives have been proposed for skin contact application such as medical adhesive tape
Adhesive, the adhesive for prosthese, ostomy appliance adhesive, is used for medical monitor at the adhesive for wound dressing
The adhesive of tool, for scar therapy treatment adhesive and transdermal drug delivery systems.Aqueous colloidal adhesive and propylene
Acid esters adhesive usually has highest adhesion strength (for example, it is desired to ceiling capacity to remove from skin).Polyurethane binder
With the second high adhesion strength, and siloxanes has the minimum adhesion strength of the skin contact adhesive of these types.With need
It those of to remove adhesive compared with low energy to compare, there are skin contact adhesives of higher adhesion strength (to need higher for those
Energy removes) during removal in may cause bigger pain and wound may be caused to skin.Certain skins connect
Touching adhesive is also possible to leave unexpected residue on the skin during removal.
During chronic wound care, adhesiveness wound dressing and/or medical adhesive tape may during more change dressings
In wound and cause pain and damage at wound circumference.Repeatedly apply and remove skin contact adhesive may bring pain and
Wound, for the patient with delicate skin.Delicate skin is usually characterized by that skin is thin and is easy to tear,
And it is more common in the elderly compared to other crowds.Aging, light exposure and heredity are the factor for causing thinning of skin.
Some drugs (oral or topical corticosteroid is such as used for a long time) are it is also possible that the blood vessel in skin and skin becomes crisp
It is weak, and make it easier to by wound associated with adhesive is removed.Individual with delicate skin can also occur in
The situation that cohesive force between epidermis and corium and between corium and subcutaneous tissue is lost, this is easier these individuals
There is a situation where skin lacerations and wound, especially when using the skin contact adhesive with higher adhesion strength.
In addition, silicone adhesive (for example, by two parts those of silicone elastomer preparation of catalysis) may be uncomfortable
Such as transdermal drug delivery is applied for certain skin contact adhesives.It is used to prepare certain catalyst of silicone elastomer
(such as, for the platinum metal catalysts of Si―H addition reaction) may negatively affect the medicinal actives in transdermal drug delivery device
Ingredient.
In addition to skin contact adhesive, polyurethane and polysiloxane are also used for the painting being applied in various substrates
Material.Known polyurethane has high mechanical tenacity, but has some defects, and such as temperature tolerance, moisture-proof and irradiation stability are limited.
Polysiloxane is highly stable at ambient conditions.Some polysiloxane are incorporated into the coating based on polyurethane
There are challenges in industry, because the chemical property of polysiloxane and polyurethane makes it have the compatibility being very limited.
Problem to be solved
Industry, which needs to develop, can be used for being formed the skin contact adhesive with one or more of following benefit
Composition: good bond properties, the ability (for example, transdermal drug delivery application in) of transfer activity ingredient, moisture-proof (from
Environment is to skin), conveying of the water from skin to environment, stability, minimum skin irritatin, during using and removing to skin
Damage it is minimum and/or residue during removal and after removing on skin is minimum.Industry also needs to develop one kind
The composition that can be used for being formed on the substrate coating, with one or more of following benefit: in polyurethane and silicon oxygen
Improved compatibility, improved weatherability, hydrophobicity, hydrolytic stability, radiation resistance, heat resistance, corrosion resistance between alkane,
Surface smoothness and gloss, scratch resistance, under similar solid content relatively low viscosity (influence volatile organic content,
VOC) and friction reduces.
Summary of the invention
Copolymer compositions include two or more initial substances.Copolymer compositions include copolymer (A) and are copolymerized
At least one of object (B), wherein copolymer (A) is organic-silicone copolymers of the unit comprising following formula:
Wherein
Each RDIt independently is divalent hydrocarbyl mission or divalent halogenated hydrocarbon group;
Each RMIt independently is monovalent hydrocarbon radical or monovalence halogenated hydrocarbon group;
Each RTIt independently is hydrogen or hydrocarbyl group;
Each subscript b is independently 0 to 1,000,000;
Subscript c be 0 to 200,000, subscript i be 0 to 200,000, subscript w1 be 0 to 200,000, subscript w2 be 0 to
200,000, subscript w3 are 0 to 200,000, and subscript w4 is 0 to 200,000, and quantity (c+i+w1+w2+w3+w4) >=1;
Subscript d is 0 to 1,000,000;
Subscript e is 0 to 1,000,000;
Subscript f is 0 to 1,500,000;
Subscript h >=0;
Subscript j1 >=0;
Each X independently is nitrogen, oxygen or sulphur;
When X is oxygen or sulphur, subscript o=0, and when X is nitrogen, subscript o=1;
Subscript r is 0 to 1,500,000, and quantity f+r >=1;
Subscript s is 0 to 200,000;And
Subscript v is 0 to 200,000;
Subscript y is >=0;
And copolymer (B) is organic-silicone copolymers of the unit comprising following formula:
Wherein RT、RD、RMAnd subscript o, l, s, v, r, c, I, w1, w2, w3, w4, b and y are such as above with respect to copolymer
(A) it is defined, and subscript j2 > 0, and if j1 > 0, j2/j1 >=1.1.Copolymer (A) and copolymer (B) are each other not
Together.The blend also may include one or both of following substance:
(C) organic polyhydric alcohol;Or
(D) reaction product of organic multiple isocyanate and organic polyhydric alcohol.
Skin contact adhesive composition includes above-mentioned copolymer compositions, and skin contact adhesive composition hardens
To form skin contact adhesive.Skin contact adhesive can be used in various skin contact adhesive applications, comprising: for curing
With the adhesive of adhesive tape, the adhesive for wound dressing, the adhesive for prosthese, ostomy appliance adhesive, for curing
With monitoring utensil adhesive, for scar therapy treatment adhesive, for the adhesive and transdermal medicine of cosmetics drug paste
Object delivery system.
Coating composition includes above-mentioned copolymer compositions.Coating composition can be applied in various substrates, and can
Coating is formed on the substrate to harden.
Detailed description of the invention
Fig. 1 be include skin contact adhesive as described herein laminate 100 partial cross-section.
The wound that Fig. 2A shows 200 form of adhesive bandage including skin contact adhesive 202 as described herein applies
The perspective view of material.
Fig. 3 shows the wound dressing of 300 form of laminate including skin contact adhesive 308 as described herein
Partial cross-section.
It is including flange used in the ostomy appliance of skin contact adhesive 402 as described herein that Fig. 4, which is shown,
400。
Appended drawing reference
The opposite surface of 100 laminate, 303 supporter
101 supporter, 304 supporter
The surface towards skin of 102 skin contact adhesive, 305 supporter
103 release liner, 306 absorbed layer
The opposite surface of 104 307 skin contact adhesives of surface towards skin
308 skin contact adhesive of surface of 105 contact skins
The surface towards skin of 200 adhesive bandage, 309 skin contact adhesive
201 absorbed layer, 310 release liner
202 skin contact adhesive, 400 flange
203 401 supporting members of surface towards skin
204 supporter, 402 skin contact adhesive
205 skin contact surface, 403 hole
300 laminates
The opposite surface of 301 carriers
302 carriers
Specific embodiment
Copolymer compositions include at least one of copolymer (A) and copolymer (B).The copolymer compositions can be optional
Ground also includes one or both of following substance: initial substance (C): organic polyhydric alcohol;And initial substance (D): You Jiduo
The reaction product of isocyanates and organic polyhydric alcohol.The copolymer compositions include at least two initial substances.The copolymer group
Closing object may include (A) and (B).Alternatively, the copolymer compositions may include (A) and (C).Alternatively, the copolymer compositions can wrap
Containing (B) and (C).Alternatively, the copolymer compositions may include (A) and (D).Alternatively, the copolymer compositions may include (B) and
(D).Alternatively, the copolymer compositions may include (A), (B) and (C).Alternatively, the copolymer compositions may include (A), (B) and
(D).Alternatively, the copolymer compositions may include (A), (C) and (D).Alternatively, the copolymer compositions may include (B), (C) and
(D).Alternatively, the copolymer compositions may include (A), (B), (C) and (D).
Copolymer (A)
Copolymer (A) is organic-silicone copolymers.Copolymer (A) includes the unit of following formula:
In said units formula, each RDIt independently is divalent hydrocarbyl mission or divalent halogenated hydrocarbon group, as defined below.
Each RDCan independently have 2 to 13 carbon atoms.Alternatively, each RDIt can be selected from alkylidene such as ethylidene or propylidene, sub- virtue
Base such as phenylene or sub- aralkyl.Alternatively, each RDIt can be alkylidene group, such as ethylidene or propylidene.
Each RMIt independently is monovalent hydrocarbon radical or monovalence halogenated hydrocarbon group, as defined below.Each RMCan have 1 to
13 carbon atoms.Alternatively, each RMIt can be the monovalent hydrocarbon radical without aliphatic degree of unsaturation.For example, each RMIt can be independently selected from
Alkyl, such as methyl, ethyl, propyl, butyl or hexyl;Aryl such as phenyl or aralkyl such as tolyl, xylyl or
Phenyl methyl.Alternatively, each RMIt can be methyl or phenyl, and each RMIt can be methyl.
Each RTFor hydrogen or monovalent hydrocarbon radical.RTMonovalent hydrocarbon radical can have 1 to 13 carbon atom.RTMonovalent hydrocarbon
Group is independently selected from alkyl, such as methyl, ethyl, propyl, butyl or hexyl;Aryl, such as phenyl;Or aralkyl, such as first
The group of phenyl, xylyl or phenyl methyl.Alternatively, each RTIt can be methyl or phenyl.Alternatively, each RTIt can be hydrogen or first
Base.
Each subscript b is independently greater than or is equal to 0.Each example of subscript b can have in the different units of copolymer
Different value.Alternatively, subscript b is 0 to 1,000,000.Alternatively, subscript b is 0 to 200,000.Alternatively, subscript b is 0 to 100,
000.Alternatively, subscript b is 0 to 50,000.Alternatively, subscript b is 0 to 10,000.Alternatively, subscript b is 0 to 5,000.Under alternatively,
Marking b is 0 to 1,000.Alternatively, subscript b is 0 to 500.Alternatively, subscript b is 0 to 100.Alternatively, subscript b is 1 to 100.Alternatively,
Subscript b is 1 to 50.Alternatively, subscript b is 1 to 20.Alternatively, subscript b is 0 to 1.Alternatively, subscript b=1.Alternatively, subscript b=2.
Alternatively, subscript b=3.Alternatively, subscript b=4.Alternatively, subscript b=5.
Subscript c >=0.Alternatively, subscript c is 0 to 200,000.Alternatively, subscript c is 0 to 100,000.Alternatively, subscript c is 0
To 50,000.Alternatively, subscript c is 0 to 10,000.Alternatively, subscript c is 0 to 5,000.Alternatively, subscript c is 0 to 1,000.Or
Person, subscript c are 0 to 500.Alternatively, subscript c is 0 to 100.Alternatively, subscript c is 0 to 50.Alternatively, subscript c is 0 to 20.Alternatively,
Subscript c is 0 to 10.Alternatively, subscript c is 1 to 100.Alternatively, subscript c is 1 to 50.Alternatively, subscript c is 1 to 20.Alternatively, subscript
C is 1 to 10.
Subscript i >=0.Alternatively, subscript i is 0 to 200,000.Alternatively, subscript i is 0 to 100,000.Alternatively, subscript i is 0
To 50,000.Alternatively, subscript i is 0 to 10,000.Alternatively, subscript i is 0 to 5,000.Alternatively, subscript i is 0 to 1,000.Or
Person, subscript i are 0 to 500.Alternatively, subscript i is 0 to 100.Alternatively, subscript i is 0 to 50.Alternatively, subscript i is 0 to 20.Alternatively,
Subscript i is 0 to 10.Alternatively, subscript i is 1 to 100.Alternatively, subscript i is 1 to 50.Alternatively, subscript i is 1 to 20.Alternatively, subscript
I is 1 to 10.
Subscript w1 >=0.Alternatively, subscript w1 is 0 to 200,000.Alternatively, subscript w1 is 0 to 50,000.Alternatively, subscript w1
It is 0 to 10,000.Alternatively, subscript w1 is 0 to 5,000.Alternatively, subscript w1 is 0 to 1,000.Alternatively, subscript w1 is 0 to 500.
Alternatively, subscript w1 is 0 to 100.Alternatively, subscript w1 is 0 to 50.Alternatively, subscript w1 is 0 to 20.Alternatively, subscript w1 is 0 to 10.
Alternatively, subscript w1 is 1 to 100.Alternatively, subscript w1 is 1 to 50.Alternatively, subscript w1 is 1 to 20.Alternatively, subscript w1 is 1 to 10.
Subscript w2 >=0.Alternatively, subscript w2 is 0 to 200,000.Alternatively, subscript w2 is 0 to 50,000.Alternatively, subscript w2
It is 0 to 10,000.Alternatively, subscript w2 is 0 to 5,000.Alternatively, subscript w2 is 0 to 1,000.Alternatively, subscript w2 is 0 to 500.
Alternatively, subscript w2 is 0 to 100.Alternatively, subscript w2 is 0 to 50.Alternatively, subscript w2 is 0 to 20.Alternatively, subscript w2 is 0 to 10.
Alternatively, subscript w2 is 1 to 100.Alternatively, subscript w2 is 1 to 50.Alternatively, subscript w2 is 1 to 20.Alternatively, subscript w2 is 1 to 10.
Subscript w3 >=0.Alternatively, subscript w3 is 0 to 200,000.Alternatively, subscript w3 is 0 to 50,000.Alternatively, subscript w3
It is 0 to 10,000.Alternatively, subscript w3 is 0 to 5,000.Alternatively, subscript w3 is 0 to 1,000.Alternatively, subscript w3 is 0 to 500.
Alternatively, subscript w3 is 0 to 100.Alternatively, subscript w3 is 0 to 50.Alternatively, subscript w3 is 0 to 20.Alternatively, subscript w3 is 0 to 10.
Alternatively, subscript w3 is 1 to 100.Alternatively, subscript w3 is 1 to 50.Alternatively, subscript w3 is 1 to 20.Alternatively, subscript w3 is 1 to 10.
Subscript w4 >=0.Alternatively, subscript w4 is 0 to 200,000.Alternatively, subscript w4 is 0 to 50,000.Alternatively, subscript w4
It is 0 to 10,000.Alternatively, subscript w4 is 0 to 5,000.Alternatively, subscript w4 is 0 to 1,000.Alternatively, subscript w4 is 0 to 500.
Alternatively, subscript w4 is 0 to 100.Alternatively, subscript w4 is 0 to 50.Alternatively, subscript w4 is 0 to 20.Alternatively, subscript w4 is 0 to 10.
Alternatively, subscript w4 is 1 to 100.Alternatively, subscript w4 is 1 to 50.Alternatively, subscript w4 is 1 to 20.Alternatively, subscript w4 is 1 to 10.
Quantity (c+i+w1+w2+w3+w4) >=1.Alternatively, in one embodiment, such as when use methanol-functionalization
Polysiloxane is come when preparing copolymer, i=w2=w4=0 as described below, and quantity (c+w1+w3) >=1.It is real in substitution
It applies in scheme, such as when using amine-functional polysiloxane to prepare copolymer, as described below, c=w1=w3=0,
And quantity (i+w1+w3) >=1.
Each X independently is nitrogen (N), oxygen (O) or sulphur (S).Alternatively, x is N or O.Alternatively, each X is N.Alternatively, each X
For O.When X is O or S, subscript o=0, and when X is N, subscript o=1.
Subscript d, e and h depend on the molecular weight of a siloxanes segment in copolymer, and can be what there is no limit
(for example, only by the constraint of the accessible molecular weight of the prior art of siloxanes synthesis chemical field).However, subscript d can for 0 to
1,000,000;Subscript e can be 0 to 1,000,000;Subscript h can be 0 to 1,000,000, precondition be quantity (d+e+h) >=
1.Subscript d >=0.Alternatively, subscript d > 0.Alternatively, subscript d is 0 to 200,000 or 0 to 100,000 or 0 to 50,000,
Or 0 to 10,000 or 0 to 5,000 or 0 to 1,000 or 1 to 1,000 perhaps 1 to 500 and 1 to
200。
Subscript e >=0.Alternatively, subscript e is 0 to 1,000,000.Alternatively, subscript e be 0 to 200,000, and 0 to
100,000 or 0 to 50,000 or 0 to 10,000 or 0 to 5,000 or 0 to 1,000 or 1 to 1,000, or
Person 1 to 500, and 1 to 200.Alternatively, subscript e=0.
Subscript f indicates the quantity of carbamate and/or urea unit in copolymer.Subscript f >=0.Alternatively, subscript f be 0 to
1,500,000.Alternatively, subscript f is 1 to 500,000, and 1 to 200,000 or 1 to 50,000 or 1 to 10,
000 or 1 to 5,000 or 1 to 1,000 perhaps 1 to 500 and 1 to 200.
Subscript h >=0.Alternatively, subscript h is 0 to 1,000,000.Alternatively, subscript h be 0 to 200,000, and 0 to
100,000 or 0 to 50,000 or 0 to 10,000 or 0 to 5,000 or 0 to 1,000 or 1 to 1,000, or
Person 1 to 500, and 1 to 200.Alternatively, subscript h=0.
Subscript j1 >=0.Alternatively, subscript j1 is > 0 to 500,000.Alternatively, subscript j1 is > 0 to 200,000, and
20 to 100,000 or 50 to 50,000 or 100 to 10,000 or 1,000 to 5,000 or 100 to 1,000, or
Person 10 to 500, and 15 to 200.
Subscript s >=0.Alternatively, subscript s is 0 to 200,000.Alternatively, subscript s be 0 to 150,000, and 0 to
100,000 or 0 to 50,000 or 1 to 10,000 or 1 to 5,000 or 1 to 1,000 or 1 to 500, and
Or 1 to 200.
Subscript v >=0.Alternatively, subscript v is 0 to 200,000.Alternatively, subscript v be 0 to 150,000, and 0 to
100,000 or 0 to 50,000 or 1 to 10,000 or 1 to 5,000 or 1 to 1,000 or 1 to 500, and
Or 1 to 200.
Subscript y >=0.Alternatively, subscript y is 0 to 200,000.Alternatively, subscript y be 0 to 150,000, and 0 to
100,000 or 0 to 50,000 or 1 to 10,000 or 1 to 5,000 or 1 to 1,000 perhaps 1 to 500 or
1 to 200 perhaps 1 to 20 and 1.
Alternatively, copolymer (A) can have unit formula (I) as subscript c=i=w2=w3=w4=e=h=0:
-[-O-RD- OH], wherein RDAnd RMAs described above.Each subscript a is independently 0 to 1,000,000, each subscript m
It is independently greater than or equal to 0, each subscript b is independently greater than or is equal to 0, and subscript n is greater than or equal to 1.Alternatively, under each
Mark b >=0.Alternatively, subscript b is 0 to 1,000,000.Alternatively, subscript b is 0 to 200,000.Alternatively, subscript b is 0 to 100,
000.Alternatively, subscript b is 0 to 50,000.Alternatively, subscript b is 0 to 10,000.Alternatively, subscript b is 0 to 5,000.Under alternatively,
Marking b is 0 to 1,000.Alternatively, subscript b is 0 to 500.Alternatively, subscript b is 0 to 100.Alternatively, subscript b is 1 to 100.Alternatively,
Subscript b is 1 to 50.Alternatively, subscript b is 1 to 20.Alternatively, subscript b is 0 to 1.Alternatively, subscript b=0.Alternatively, subscript b=1.
Alternatively, subscript b=2.Alternatively, subscript b=3.Alternatively, subscript b=4.Alternatively, subscript b=5.
Alternatively, copolymer (A) can have formula (II):
,
Wherein RDAnd RMAs described above, subscript a is independently 0 to 1,000,000, each subscript b is independently greater than or is equal to
0, and subscript n is greater than or equal to 1.Alternatively, each subscript b >=0.Alternatively, subscript b is 0 to 1,000,000.Alternatively, subscript b
It is 0 to 200,000.Alternatively, subscript b is 0 to 100,000.Alternatively, subscript b is 0 to 50,000.Alternatively, subscript b is 0 to 10,
000.Alternatively, subscript b is 0 to 5,000.Alternatively, subscript b is 0 to 1,000.Alternatively, subscript b is 0 to 500.Alternatively, subscript b is
0 to 100.Alternatively, subscript b is 1 to 100.Alternatively, subscript b is 1 to 50.Alternatively, subscript b is 1 to 20.Alternatively, subscript b be 0 to
1.Alternatively, subscript b=0.Alternatively, subscript b=1.Alternatively, subscript b=2.Alternatively, subscript b=3.Alternatively, subscript b=4.Alternatively,
Subscript b=5.
Copolymer (B)
Copolymer (B) is siloxanes-carbamate-urea copolymer, and it includes the units of following formula:
Wherein RT、RD、RMAnd subscript o, l, s, v, r, c, i, w1, w2, w3, w4, b and y are such as above with respect to altogether
Polymers (A) is defined, and subscript j2 > 0.When copolymer (A) and copolymer (B) are present in copolymer compositions, and
And as j1 > 0, then j2/j1 >=1.1.Alternatively, subscript j2 is 1 to 500,000.Alternatively, subscript j2 is 1 to 200,000, or
20 to 100,000 or 50 to 50,000 or 100 to 10,000 or 1,000 to 5,000 or 100 to 1,000, or
Person 10 to 500, and 15 to 200.
Alternatively, copolymer (B) can have unit formula (III):
Wherein RD、RM, subscript a, b and n as described above, and subscript n 1 be greater than or equal to 0, or be 0 to 200,000 or 0
To 20,000 or 0 to 10,000 or 0 to 5,000 or 0 to 1,000 perhaps 0 to 100 or 1 to 50.Subscript n 2
0 or 1, and quantity (n2+n3)=1 are respectively with n3.
(C) organic polyhydric alcohol
Initial substance (C) is organic polyhydric alcohol.Suitable organic polyhydric alcohol is containing two or more hydroxyl groups
Organic polymer.Organic polyhydric alcohol for initial substance (C) can be polyether polyol, polyester polyol, polyacrylate
Polyalcohol, polycaprolactone polyol, polyurethane polyol, polycarbonate polyol, polybutadiene diol, other polymers are polynary
Two or more in alcohol or these organic polyhydric alcohols.Also the copolymerization of the polymer of two or more seed types can be used
Object polyalcohol.Also can be used on polymer architecture there are other to modify such as fluorinated polyalcohol.Alternatively, suitable organic
Polyalcohol can be organic polymer glycol.This organic polymer glycol includes polyoxyalkylene glycol, such as polyoxygenated
Ethylidene glycol, oxide glycols and polyoxybutylene glycol;Or polycarbonate glycol.Alternatively, suitable organic
Polyalcohol can be small molecule organic diol.This micromolecular organic diol includes glycerol.Organic polyhydric alcohol can be added to adjust
The surface energy and/or hydrophily/mechanical performance of copolymer compositions.Additive amount can be 0% to 95% or 0% to 75%, or
Person 0% to 50%, and 1% to 25%.
(D) reaction product of organic multiple isocyanate and organic polyhydric alcohol
Initial substance (D) can be by making initial substance (C), and above-mentioned organic polyhydric alcohol is reacted with isocyanate compound to be come
Preparation, the isocyanate compound per molecule have average one or more isocyanate groups.Alternatively, organic isocyanate
Two or more average isocyanate groups can be had by closing object per molecule.Organic isocyanate compound can have following formula: R-
(N=C=O)p, wherein R is hydrocarbyl group or halogenated hydrocarbon group, and subscript p is to indicate isocyanate groups quantity in per molecule
Integer, and p be greater than or equal to 1.Alternatively, subscript p is 2,3 or 4;Alternatively, subscript p is 2 or 3;And alternatively, subscript p is
2.When subscript p is 2, R is divalent hydrocarbyl mission.When subscript p is 3, R is trivalent hydrocarbon radical group.When subscript p is 4, R is tetravalence
Hydrocarbyl group.
The example of organic isocyanate compound is monomeric diisocyanate and polymeric isocyanate.Monomeric diisocyanate includes
Aromatic diisocyanates, such as between tetramethylxylene diisocyanate (TMXDI), toluene di-isocyanate(TDI) (TDI), phenylene
Diisocyanate, xylene diisocyanate, 1,5- naphthalene diisocyanate, chlorine phenylene 2,4- diisocyanate, dimethylbenzene two
Isocyanates, dianisidine diisocyanate, toluidine diisocyanate and alkylated benzene diisocyanates;It is aliphatic and alicyclic
Isocyanates, such as hexamethylene diisocyanate (HDI), hydrogenated methylene diphenyl diisocyanate (HMDI), 1- isocyanide
Acidic group -3- isocyanatometyl -3,5,5- trimethyl-cyclohexane (isophorone diisocyanate, IPDI) and three isocyanide of nonyl
Acid esters (TTI), the aromatic diisocyanates that methylene interrupts, such as methylene-diphenyl-diisocyanate, especially 4,4'-
Isomers (MDI), including alkylated analogs, such as 3,3'- dimethyl -4,4'- diphenyl-methane diisocyanate;Hydrogenation
Substance, such as cyclohexylene diisocyanate, 4,4'- methylene biscyclohexyl diisocyanate;Mix aralkyl diisocyanate
Ester, such as tetramethyl xylene phenyl diisocyanate, Isosorbide-5-Nitrae-bis- (1- isocyanate group -1,1'- dimethyl methyl) benzene, OCNC
(CH3)2C6H4C(CH3)2NCO and polymethylene isocyanates, such as Isosorbide-5-Nitrae-tetramethylene diisocyanate, 1,5-, five methylene
Group diisocyanate, 1,6- hexamethylene diisocyanate (HDI), 1,7- heptamethylene diisocyanate, 2,2,4- and 2,4,
4- trimethyl hexamethylene diisocyanate, 1,10- decamethylene diisocyanate and 2- methyl-1, two isocyanide of 5- pentamethylene
Acid esters;Vinyl isocyanate;And their combination.
Polymerizeing organic isocyanate includes isocyanate dimerization urea diketone or urea diacetyl and carbodiimide, cyamelide
Ester isocyanuric acid ester, imidoyl-oxadiazine-diketone, uretonimine and linear polymer α-nylon;And derivative isocyanic acid
Ester to form allophanate or biuretized by reacting Bifunctionalized or multiple functionalized isocyanates with various compounds
Close object or isocyanate-functional carbamate or other prepolymers.Some polyisocyanates be it is Bifunctionalized, i.e., every point
Son has 2 isocyanate groups.Some isocyanate groups having more than two.Another example is polymeric diphenylmethanes two
Isocyanates is, the mixture of the molecule of three and four or more isocyanate groups that be averaged function there are two tools
Degree can be greater than two, usually 2.7.Isocyanate functional compound of the isocyanate functionality greater than two may act as crosslink sites.
Commercially available isocyanate-functional organic compound is with the Tolonate XIDT 70SB (Rhodia in the New Jersey city Crane Bai Li
A kind of isophorone diisocyanate tripolymer (70% solid, 12.3 weights of company (Rhodia, Cranbury, NJ) sale
Amount %NCO)) and Desmodur N-100 polyisocyanates (derived from Mobay company) be illustrated.
Alternatively, organic isocyanate compound can be blocked isocyanate.Isocyanate groups can be by common envelope
Hold agent (such as, phenol, nonyl phenol, diacetylmonoxime, caprolactam etc.) sealing end.These blocked isocyanates can be at a certain temperature
Release, to be reacted with chain extender and polysiloxane, to construct organic-silicone copolymers.End-capping reagent can be by adding
Heat is reacted/is discharged to certain temperature.
Reaction product (D) can be low molecular weight compound, or with the prepolymer or macromolecule down to intermediate molecular weight
Weight polymers, this degree for depending on isocyanates/OH reactive group molar ratio and being reacted.Organic polyhydric alcohol can have
There are relatively large molecular weight and lower glass transition temperatures (Tg) to be formed in the reaction product a part of " soft chain segment ", or
With low molecular weight to form " hard segment " in the reaction product.Depending on the molar ratio of polyalcohol and isocyanates and anti-
It answers, reaction product (D) can have remaining hydroxyl group or isocyanate groups or isocyanate groups and hydroxyl group two
Person, or without remaining reactive group.
Method by initial substance (i.e. the pure and mild polyisocyanates of organic multicomponent) preparation reaction product (D) is known, and
And it can be using any conventional method for preparing polyether polyols.Such methods are found in United States Patent (USP) 3,384,623,5,
200,491 and 5,621,024.The method for being used to prepare copolymer (A)
The method that the method for preparing copolymer (A) is similar to preparation reaction product (D).It can be used above-cited with reference to text
Method described in offering, but initial substance is become into those described herein substance.
The above-mentioned copolymer as initial substance (A) can be by including prepared by the method for following procedure:
1) make include the following terms initial substance reaction:
A) isocyanate compound,
B) polysiloxane, and
C) chain extender.
In one embodiment, all initial substances can be combined and make its simultaneous reactions.Alternatively, can make comprising a) isocyanide
The initial substance of ester compound and b) polysiloxane is reacted to form prepolymer, and then can make prepolymer with comprising
C) reaction of the initial substance of chain extender and a) isocyanate compound of optionally other amount is to form copolymer.Alternatively, can
Make comprising a) isocyanate compound and c) initial substance of chain extender is reacted to form intermediate, and then can make intermediate
It is reacted with the initial substance comprising b) polysiloxane and a) isocyanate compound of optionally other amount to be formed altogether
Polymers.
In all these embodiments, no matter polysiloxane wherein reacts, and can use poly organo
The mixture of alkane and organic polyhydric alcohol replaces polysiloxane.Alternatively, this method can include: i) make a) isocyanate compound
Reacted with b) polysiloxane and d) organic polyhydric alcohol to form prepolymer, and then ii) make prepolymer and c) chain extender
A) the isocyanate compound of optionally other amount reacts.
In each embodiment of the above method, initial substance b) polysiloxane can be b1) methanol-functionalization
Polysiloxane, b2) amine-functional polysiloxane or b1) and mixture b2).
Initial substance a) isocyanate compound
In the above-mentioned methods, a) isocyanate compound per molecule has average one or more isocyanate groups.Or
Person, isocyanate compound per molecule can have two or more average isocyanate groups.Isocyanate compound can have
There is following formula: R- (N=C=O)p, wherein R is polyvalent hydrocarbon radicals or multivalence halogenated hydrocarbon group, and subscript p is to indicate in per molecule
The integer of isocyanate groups quantity.Subscript p is greater than or equal to 1.Alternatively, subscript p is 2,3 or 4;Alternatively, subscript p is 2 or 3;
And alternatively, subscript p is 2.When subscript p is 2, R is divalent hydrocarbyl mission.When subscript p is 3, R is trivalent hydrocarbon radical group.Instantly
When mark p is 4, R is tetravalence hydrocarbyl group.
The example of isocyanate compound is monomeric diisocyanate and polymeric isocyanate.Monomeric diisocyanate includes aromatics
Diisocyanate, such as between tetramethylxylene diisocyanate (TMXDI), toluene di-isocyanate(TDI) (TDI), phenylene two it is different
Cyanate, xylene diisocyanate, 1,5- naphthalene diisocyanate, chlorine phenylene 2,4- diisocyanate, two isocyanide of dimethylbenzene
Acid esters, dianisidine diisocyanate, toluidine diisocyanate and alkylated benzene diisocyanates;Aliphatic and alicyclic isocyanide
Acid esters, such as hexamethylene diisocyanate (HDI), hydrogenated methylene diphenyl diisocyanate (HMDI), 1- isocyanate group-
3- isocyanatometyl -3,5,5- trimethyl-cyclohexane (isophorone diisocyanate, IPDI) and nonyl triisocyanate
(TTI), the aromatic diisocyanates that methylene interrupts, such as methylene-diphenyl-diisocyanate, especially 4,4'- isomery
Body (MDI), including alkylated analogs, such as 3,3'- dimethyl -4,4'- diphenyl-methane diisocyanate;Hydrogenation material,
Such as cyclohexylene diisocyanate, 4,4'- methylene biscyclohexyl diisocyanate;Aralkyl diisocyanates are mixed, it is all
Such as tetramethyl xylene phenyl diisocyanate, 1,4- bis- (1- isocyanate group -1,1'- dimethyl methyl) benzene, OCNC (CH3)2C6H4C(CH3)2NCO and polymethylene isocyanates, such as Isosorbide-5-Nitrae-tetramethylene diisocyanate, 1,5- pentamethylene two
Isocyanates, 1,6- hexamethylene diisocyanate (HDI), 1,7- heptamethylene diisocyanate, 2,2,4- and 2,4,4- tri-
Methyl hexamethylene diisocyanate, 1,10- decamethylene diisocyanate and 2- methyl-1,5- pentamethylene diisocyanate
Ester, vinyl isocyanate;And their combination.
Polymeric isocyanate include isocyanate dimerization, urea diketone or urea diacetyl and carbodiimide, isocyanuric acid ester,
Isocyanuric acid ester, imidoyl-oxadiazine-diketone, uretonimine and linear polymer α-nylon;And derivative isocyanates,
By making Bifunctionalized or multiple functionalized isocyanates react to form allophanate or biuret chemical combination with various compounds
Object or isocyanate-functional carbamate or other prepolymers.Some polyisocyanates are Bifunctionalized, i.e. per molecules
With 2 isocyanate groups.Some isocyanate groups having more than two.Another example is polymeric diphenylmethane two is different
Cyanate is there are two tools, the mixture of the molecule of three and four or more isocyanate groups, average functionality
Two, usually 2.7 can be greater than.Isocyanate functional compound of the isocyanate functionality greater than two may act as crosslink sites.City
(Rhodia in the New Jersey city Crane Bai Li is public with Tolonate XIDT 70SB for the isocyanate-functional organic compound sold
Take charge of a kind of isophorone diisocyanate tripolymer (70% solid, the 12.3 weight % of (Rhodia, Cranbury, NJ) sale
NCO it)) is illustrated with Desmodur N-100 polyisocyanates (deriving from Mobay company).
Alternatively, a) isocyanate compound may include blocked isocyanate.Isocyanate groups can be by common sealing end
Agent (such as, phenol, nonyl phenol, diacetylmonoxime, caprolactam etc.) sealing end.These blocked isocyanates can pass through any routine side
Method release, is such as heated at temperatures greater than room temperature to react with chain extender and polysiloxane, to construct polyurethane-
Poly organo alkyl copolymer.
Initial substance b1) methanol-functional organo-siloxanes
In the above-mentioned methods, b1) unit of the methanol-functional organo-siloxanes comprising following formula:
In this is modular, each RM、RD, subscript b, subscript c, subscript w1, subscript w3, subscript d, subscript e and subscript h institute as above
It states.Methanol-functional organo-siloxanes example in WO2008/088491, United States Patent (USP) 6,528,121 and United States Patent (USP) 7,
It is disclosed in 452,956.Methanol groups can be located at end or side chain.Alternatively, methanol groups can be located at end.
Alternatively, b1) methanol-functional organo-siloxanes may include lower formula (II) α, ω-Bifunctionalized poly- two is organic
Siloxanes: RCRM 2Si-RDX-(RM 2SiO)r-(RM 2)SiRDX-SiRM 2RC, wherein each RCIt independently is formula HO-RD-(ORD)b?
Methanol functional group, wherein subscript b, RMAnd RDAs described above, each RDXIndependently selected from O or as above according to RDThe divalent hydrocarbon
Group, and subscript r indicates methanol-functional organo-siloxanes degree of polymerization of formula (II).Subscript r > 0.Alternatively, subscript r
It can be 1 to 1,000,000 or 50 to 1,000, and 200 to 700.Alternatively, subscript r is 0 to 200,000 or 0
To 200,000 or 0 to 100,000 or 0 to 50,000 or 0 to 10,000 or 0 to 5,000 or 0 to 1,
000 or 1 to 1,000 perhaps 1 to 500 perhaps 1 to 200 and 5 to 150.Alternatively, each RDXFor O.
Initial substance b2) amine-functional polysiloxane
Amine-functionalized polysiloxane includes the unit of following formula:
Wherein RMAnd RDAnd subscript b, d, e, h and i are as described above.Amine groups can be located at end or side chain.Alternatively, amine groups
End can be located at.
The polysiloxane of exemplary amines sealing end includes the terminal units of following formula:
Wherein Me indicates methyl group, and Bu indicates butyl group;And also comprising containing (RM 2SiO2/2)d(RMSiO3/2)e
(SiO4/2)hOne of or a variety of units, wherein RM、RDAnd subscript i, d, e and h are as described above.
Initial substance c) chain extender
Chain extender can be formula HO-RDThe dihydric alcohol of-OH, wherein RDAs defined above.Suitable dihydric alcohol includes 1,3- fourth
Glycol;1,4- butanediol;1,6-HD, 1,10- decanediol;1,6- hexamethylene glycol;2,2- dimethyl -1,3- the third two
Alcohol;1,4 cyclohexane dimethanol;- two -2- ethyl alcohol of 1,1'- isopropylidene-bis--(p-phenylene-oxygroup);Poly- (tetramethylene
Ether) glycol;And ethylene glycol.Alternatively, chain extender can be the diamines containing 2 to 20 carbon atoms, such as 1,2- diamino second
Alkane;1,4- diaminobutane;1,2- propane diamine;Hexamethylene diamine;Diethylenediamine;5- amino -1- (amino methyl) -1,
3,3- trimethyl-cyclohexane;4,4' methylene bis (cyclohexylamine);And ethanol amine.Alternatively, chain extender can be two mercaptan, two
Carboxylic acid or dicyclic oxide.Suitable chain extender discloses in such as United States Patent (USP) 4,840,796 and 5,756,572.
Initial substance d) solvent
Solvent can be added during this method to prepare copolymer described herein.It will dissolution copolymer and relatively not
Any organic compound reacted with isocyanates and amine and/or carbinol compound is suitable as solvent.Example include aliphatic hydrocarbon,
Aromatic hydrocarbon, ester, ether, ketone and amide.Exemplary solvent includes methyl ethyl ketone, ethyl acetate, butyl acetate or tetrahydrofuran.
The amount of solvent for use depends on the performance (certain party including the preparation of structure, molecular weight and copolymer of copolymer
Method), and can be 0 to 99%.Generally for the copolymer of higher molecular weight, especially when without using high torque mixing machinery
When, solvent can be added to reduce viscosity and system is made to be easier to handle during the progress for the method for preparing copolymer.If point
Son amount is relatively low and/or uses high torque mixing apparatus such as double screw extruder, then does not need using solvent.When use solvent
When, based on the combination weight of all initial substances used, amount can for 0% to 99% perhaps 0% to 80% or 1% to
60%, and 5% to 50%.
According to desired poly organo alkyl structure and molecular weight, initial substance a), b), c) and d) and/or e) (when depositing
When) amount can be widely varied, to obtain copolymer described in the formula of this paper.The isocyanate groups of initial substance a) be directed to
The molar ratio of the reactive hydrogen of methanol or amine groups on the selected polysiloxanes of initial substance b) can be 0.1 to 100, or
0.1 to 50 perhaps 0.1 to 10 perhaps 0.1 to 2 perhaps 0.1 to 1.5 perhaps 0.1 to 1.25 perhaps 0.1 to 1.1 or
0.1 to 1.05 perhaps 0.1 to 1.01 perhaps 0.1 to 1 perhaps 0.1 to 0.9 perhaps 0.1 to 0.5 perhaps 0.5 to 50 or
0.5 to 10 perhaps 0.5 to 2 perhaps 0.5 to 1.5 perhaps 0.5 to 1.25 perhaps 0.5 to 1.1 perhaps 0.5 to 1.05 or
0.5 to 1.01 perhaps 0.5 to 1 perhaps 0.5 to 0.9 and 0.4 to 0.7.
Between the reactive hydrogen on the hydroxyl or amine groups or other reactive groups on isocyanate groups and chain extender
Molar ratio can be 1.001 to 1,000,000 or 1.001 to 500,000 or 1.001 to 200,000 or 1.001
To 100,000 or 1.001 to 50,000 or 1.001 to 10,000 or 1.001 to 5,000 or 1.001 to 1,
000 perhaps 1.001 to 500 perhaps 1.001 to 100 perhaps 1.001 to 50 perhaps 1.001 to 20 or 1.001 to 10,
Perhaps 1.001 to 5 perhaps 1.001 to 4 perhaps 1.001 to 3 perhaps 1.001 to 2 perhaps 1.001 to 1.5 or 1.001
To 1.3 perhaps 1.001 to 1.2 perhaps 1.01 to 20 perhaps 1.01 to 10 perhaps 1.01 to 5 perhaps 1.01 to 4 or
1.01 to 3 perhaps 1.01 to 2 perhaps 1.01 to 1.5 perhaps 1.01 to 1.3 and 1.01 to 1.2.
Initial substance e) catalyst
It can be catalyzed by initial substance e) catalyst comprising above-mentioned initial substance reaction a), b) and c).Suitably
Catalyst includes tertiary amine and metal salt, such as the salt of tin.The tin compound that can be used as the catalyst of this paper includes the oxygen of wherein tin
Change state is those of+4 or+2 compounds, i.e. tin (IV) compound or tin (II) compound.The example of tin (IV) compound includes
Stannic salt, such as dibutyl tin dilaurate, dilaurate, two (normal-butyl) diketone tin, dibutyltin diacetate,
Dibutyitin maleate, dibutyl tin diacetyl acetonate, dimethoxy dibutyl tin, three suberic acid methoxycarbonyl phenyltins, two
Sad dibutyl tin, dioctyl phthalate dibutyl tin, three cerinic acid isobutyl group tin, two butyric acid stannous methides, two neodecanoic acid stannous methides, two
Neodecanoic acid dibutyl tin, tartaric acid tin triethyl, dibenzoic acid dibutyl tin, three -2 ethyl hexanoic acid butyl tins, oxalic acid two are pungent
Ji Xi, tin octoate, oleic acid tin, butyric acid tin, aphthenic acids tin, dimethyltin chloride, their combination and/or their part water
Solve product.Tin (IV) compound is known in the art and is commercially available, the A Xima particularization such as from European Switzerland
Xue Pin company (Acima Specialty Chemicals, Switzerland, Europe)740 Hes
4202, the said firm is the business department of Dow Chemical (Dow Chemical Company).The example of tin (II) compound
Tin (II) salt including organic carboxyl acid, such as oxalic acid tin (II), two tin octoates (II), diethyl caproic acid tin (II), two laurels
Sour tin (II)), the tin salt of carboxylic acid, such as stannous octoate (stannous octoate), stannous oleate, stannous acetate, laurel
Sour stannous, stearic acid stannous, naphthoic acid stannous, caproic acid stannous, succinic acid stannous, stannous octoate (stannous caprylate) with
And their combination.Other metal salts are also the suitable catalyst of the reaction.Example includes zinc salt, such as zinc acetate and cycloalkanes
Sour zinc.Lead, bismuth, cobalt, iron, antimony or sodium salt such as lead octoate, bismuth nitrate and sodium acetate can also be catalyzed the reaction.In certain feelings
Under condition, organomercurial compound also can be used.Optionally co-catalyst can also be used together with above-mentioned catalyst.Alternatively, can be with
Using the combination of two or more catalyst, such as to provide reaction more achievable than single catalyst reaction faster, or
Balance reaction initiation time and deadline more preferably.
Initial substance f) organic polyhydric alcohol
Organic polyhydric alcohol is optionally combined with b) polysiloxane, to prepare above-mentioned copolymer (A) and/or copolymer
(B).Suitable organic polyhydric alcohol is the organic polymer containing two or more hydroxyl groups.For having for initial substance f)
It is more that machine polyalcohol can be polyether polyol, polyester polyol, polyacrylate polyol, polycaprolactone polyol, polyurethane
Two kinds in first alcohol, polycarbonate polyol, polybutadiene diol, other polymers polyalcohol or these organic polyhydric alcohols or
It is more kinds of.Also the copolymer polyols of the polyalcohol of two or more seed types can be used.Also it can be used in polymer knot
On structure there are other to modify such as fluorinated polymerized polyalcohol.Alternatively, suitable organic polyhydric alcohol can be organic diol.Properly
Organic diol include polyoxyalkylene glycol, such as polyoxyethylene glycol, oxide glycols and polyoxygenated
Butylen glycol;Or polycarbonate glycol.Other organic diols include glycerol.It is prepared to adjust that organic polyhydric alcohol can be added
The surface energy and/or hydrophily/mechanical performance of copolymer.Combination weight based on all initial substances for being used to prepare copolymer
Amount, additive amount can be 0% to 95% perhaps 0% to 75% perhaps 0% to 50% and 1% to 25%.
Initial substance g) optional end-capping reagent (enblocker)。
Above-mentioned copolymer (A) and/or (B) optionally with blocking agent reaction, by any remaining isocyanate groups,
Hydroxyl group or amine groups are converted into another type of reaction or non-reactive group.Suitable end-capping reagent includes but is not limited to alcohol
(such as ethyl alcohol, propyl alcohol, butanol), carboxylic acid (such as acetic acid) and the alcohol and carboxylic acid containing aliphatic degree of unsaturation.Mercaptan, azanol,
Glycol, amino acid and amino sugar also are suitable as end-capping reagent.
The method for preparing copolymer (B)。
The same procedure for being used to prepare copolymer (A) can also be used for preparing copolymer (B), the difference is that, it will change
The ratio of initial substance is to obtain desired copolymer (B) composition.It would be recognized by those skilled in the art that the copolymer of selection
(A) and copolymer (B) is different from each other.Copolymer (A) and copolymer (B) are at least one performance (such as structure, copolymer unit
Selection, copolymer unit sequence and molecular weight) on be different from each other.
Prepare the method condition of copolymer
The above method can be carried out in the case where being heated or not heated.Reaction temperature depends on initial substance a), b) and c)
Selection and with the presence or absence of any one of d), e), f) and/or g), however at 1 atmosphere pressure temperature range can-
20 DEG C to 150 DEG C;Perhaps 0 DEG C to 100 DEG C and 20 DEG C to 60 DEG C in the range of.Carry out this method pressure be not to
It closes important.
The above method can in any convenient equipment in batches, semi-batch, semicontinuous or continuous mode carry out.Work as preparation
When the copolymer of higher molecular weight (for example, when using higher molecular weight initial substance when), this method can extruder such as
It is carried out in double screw extruder.Device and method described in United States Patent (USP) 5,756,572 can be used to prepare for above-mentioned copolymer,
The difference is that using above-mentioned initial substance.
Skin contact adhesive
Skin contact adhesive can be prepared by including the method for above-mentioned hardening copolymer compositions.Hardening can lead to
It crosses any convenient mode to carry out, composition is such as cooled to 15 DEG C to 40 DEG C of room temperature, and/or moved from composition
Except solvent.The skin contact adhesive prepared by hardening copolymer compositions can be used for using such as medical adhesive tape
Adhesive, the adhesive for prosthese, ostomy appliance adhesive, is used for medical monitor at the adhesive for wound dressing
The adhesive of tool, adhesive, the adhesive for the treatment of scar therapy and transdermal drug delivery system for cosmetics drug paste
System.
Above-mentioned skin contact adhesive composition and skin contact adhesive include (I) above-mentioned copolymer compositions.Skin
Contact adhesive composition also may include (II) excipient.Above-mentioned skin contact adhesive composition and skin contact adhesive can
It optionally also include (III) active constituent.
(II) excipient
Excipient can be any ingredient different from ingredient (I) and (III), and excipient is added in composition,
To provide one or more benefits during and/or after preparing composition, and/or for skin contact adhesive provide one
Kind or a variety of benefits.For example, excipient can be (II-1) stabilizer, (II-2) binder, (II-3) filler, (II-4) solubilising
Agent, (II-5) skin penetration enhancer, (II-6) adhesion promoter, (II-7) improve penetrability reagent or (II-1), (II-
2), the combination of two or more in (II-3), (II-4), (II-5), (II-6) and (II-7).
(II-1) stabilizer
Composition is also optionally including (II-1) stabilizer.Stabilizer can include: antioxidant, such as vitamin A, dimension
Raw element E, vitamin C, retinyl palmitate, selenium, benzenpropanoic acid, bis- (1,1 the dimethyl-ethyI) -4- hydroxyls (hycroxy)-of 3,5-
C7-C9 branched alkyl ester (derived from BASF (BASF)1135), [3- (the 3,5- di-t-butyl-of pentaerythrite four
4- hydroxy phenyl) propionic ester] (derived from BASF (BASF)1010), octadecyl -3- (the tertiary fourth of 3,5- bis-
Base -4- hydroxy phenyl) propionic ester (derived from BASF (BASF)1076), 1,3,5- trimethyl -2,4,6- three
(3,5- di-tert-butyl-4-hydroxyl benzyl) benzene (equally derived from BASF (BASF)1330), 2- methyl -4,6-
Bis- [(pungent sulfenyl) methyl] phenol (derive from BASF (BASF)1520), 2,6- di-t-butyl methylphenol
(BHT), 2,2'- methylene-it is bis--(6- tert-butyl-4-methyl-Phenol) (derive from it is bright contain (LanXess) Vulkanox BKF) or
Their mixture.Alternatively, stabilizer may include amino acid, such as cysteine, methionine or their combination.Alternatively,
Stabilizer may include p-hydroxybenzoate, such as methyl p-hydroxybenzoate, propylparaben or their combination.
The amount of stabilizer depends on various factors, and whether these factors include whether by heating combination and by adding ingredient (III),
However, the weight based on composition, stabilizer can with 0% to 2% or 0% to 1% or 0.1% to 1% or
0.2% to 0.7% and 0.2% to 0.6% amount exist.
(II-2) binder
Optionally ingredient (II-2) binder is added in composition.Suitable binder includes carbohydrate and its derivative
Object is (for example, disaccharides such as sucrose and lactose, polysaccharide such as starch or cellulose or sugar alcohol such as xylitol, D-sorbite or wheat
Bud sugar alcohol.Other suitable binders include protein, such as gelatin.The amount of binder depends on various factors, including laminated
The type of product and selection to other compositions in composition, however, the weight based on composition, the amount of binder can be
0% to 50%.
(II-3) filler
Optionally ingredient (II-3) filler is added in composition.Suitable filler for ingredient (II-3)
Including but not limited to silica, to help to prevent the cold flow of composition from leaving supporter.The type of selected filler
Make the adhesion strength that can not adversely influence skin contact adhesive with amount.Weight based on composition, the amount of filler
It can be 0% to 2% or 0% to 1%.
(II-4) solubilizer
Optionally ingredient (II-4) solubilizer is added in composition.Suitable solubilizer include dimethyl sulfoxide,
Povidone (PVP) and natural oil such as mineral oil, sunflower oil and peanut oil.Ester, glycol, polyethers can help to dissolve
(III) active constituent is (that is, make ingredient (III) keep noncrystalline in composition and skin contact adhesive prepared therefrom
State, to promote active constituent to penetrate to the skin (and/or into skin)).Weight based on composition, solubilizer can
Perhaps 0% to 40% perhaps 0% to 25% to be perhaps up to 20% and 20% greater than 0% with 0% to 50%
Amount to 25% exists.Alternatively, the solubilizer suitable for ingredient (II-4) can be the above-mentioned solvent for being used to prepare copolymer.
(II-5) skin penetration enhancer
Optionally ingredient (II-5) skin penetration enhancer is added in composition.Suitable skin penetration enhancer
Including glycols, such as propylene glycol and polyethylene glycol;Organic acid, such as oleic acid;Fatty alcohol, such as oleyl alcohol;And amine.Ingredient (II-
5) amount depends on various factors, these factors include that will be applied to which aspect by the skin contact adhesive of composition preparation,
Skin contact adhesive is by the time span of application and purpose (for example, wound dressing or transdermal drug delivery), however, base
In the weight of composition, which can be in the range of 0% to less than 20% or 1% to 2%.
(II-6) adhesion promoter
Substance known in the art as skin contact adhesive can be mixed with composition as described herein, with adjustment
Binder performance, the amount of peeling force needed for such as removing skin contact adhesive and remaining residue on the skin.?
These substances can be used as adhesion promoter herein.Exemplary adhesion promoter includes aqueous colloidal.The amount of adhesion promoter
Depending on the type of selected adhesion promoter and the amount of desired adhesion strength, however, the weight based on composition, adherency promotees
Amount into agent can be 0% to less than 20% or 1% to 2%.
(II-7) improve the reagent of penetrability
Ingredient (II-7) is the reagent for improving penetrability, and optionally the reagent is added in composition.For ingredient
(II-7) suitable reagent includes but is not limited to aqueous colloidal, gelatin, polymer such as CMC carboxymethyl cellulose and polyoxygenated
Ethylene.The amount of ingredient (II-7) depends on various factors, these factors include selection to other compositions in composition and by
The final use of its skin contact adhesive prepared.However, the weight based on composition, the amount of ingredient (II-7) can be
0.1% to 50% or 0.1% to 25% perhaps 0.1% to 10% or 1% to 10%.Those skilled in the art will recognize
Know, certain reagents for improving penetrability can function as mucoadhesive, which makes to apply when water capacity increases
Material can be adhered to preferably.
When selecting the ingredient of above-mentioned composition, overlapping may be present between component type, this is because as described herein
Certain ingredients can have more than a kind of function.For example, certain aqueous colloidals can be used as improve penetrability reagent (II-7) and
It can be used as adhesion promoter (II-6).Gelatin can be used as improving the reagent (II-7) of penetrability and can be used as binder (II-
2).Certain nutriments such as vitamin A and vitamin E can be used as stabilizer (II-1) and active constituent (III).By ingredient
When being added in composition, these ingredients are different from each other.
(III) active constituent
The composition also optionally includes (III) active constituent.For example, being used for treating acne when composition will be used to prepare
It is connect using the application of, cosmetics drug paste, transdermal drug delivery application and/or by the skin in the application of active delivery to skin
It, can be with adding ingredient (III) when touching adhesive.Given activity ingredient used is immaterial to the invention, and such as this paper institute
It is interpreted to be intended in the broadest sense to generate organism applied by it with, term " active constituent " some beneficial
The substance of effect.
Example active ingredient suitable for ingredient (III) includes but is not limited to: act on central nervous system drug,
It influences the drug of renal function, influence the drug of cardiovascular function, the drug of gastrointestinal function is influenced, for treating the medicine of vermination
Object, antimicrobial such as silver, silver compound and/or Chlorhexidine, nutriment, hormone, steroids, and for treating skin
The drug of disease;See, e.g., disclosed in 2007/0172518 [0014] section of patent application publication US those and
Those of listed in PCT Publication WO2007/092350 page 21 to 28.
Other suitable active constituents for ingredient (III) include non-steroidal anti-inflammatory drugs, such as salicylate, such as second
Acyl salicylic acid;Propanoic derivatives, such as (RS) -2- (4- (2- methyl-propyl) phenyl) propionic acid (brufen);Acetogenin, example
Such as 2- { 1- [(4- chlorphenyl) carbonyl] -5- methoxyl group -2- Methyl-1H-indole -3- base } acetic acid (Indomethacin), bmap acid spreads out
Biology;Anthranilic acid derivative, cox 2 inhibitor, for example, N- (4- hydroxy phenyl) acetamide N- (4- hydroxy phenyl) second
Amide (paracetamol) and sulfonanilide.Other suitable active constituents for ingredient (III) include local anaesthesia
Agent, such as containing those of ester group local anesthetic, for example, 4-aminobenzoic acid ethyl ester (benzocainum);Contain amide groups
Those of group local anesthetic, for example, 2- (lignocaine)-N- (2,6- 3,5-dimethylphenyl) acetamide (lidocaine);And
Natural local anesthetic, such as (1R, 2S, 5R) -2- isopropyl -5- methyl cyclohexanol (menthol).
It would be recognized by those skilled in the art that in the laminate being described below, it can be by as described herein group
It closes in object and is connect comprising ingredient (III) (that is, before hardening the composition to form skin contact adhesive) to prepare skin
Adhesive is touched, wherein to include (III) active constituent.Alternatively, can include in laminate by (III) active constituent
In independent stock, and it is not mixed into the skin contact adhesive prepared by skin contact adhesive composition.
The amount of (III) active constituent used in skin contact adhesive composition depend on various factors, these because
Element includes type of the selection for the active constituent of ingredient (III), and will wherein mix the class of the laminate of active constituent
Type, and the selection to any other ingredient in composition.However, the weight based on skin contact adhesive composition, at
The amount of point (III) can be 0% to 45%, be perhaps greater than 0% to 25% be perhaps greater than 0% to 15% or be greater than 0% to
10%, perhaps it is greater than 0.1% to 10% or greater than 1% to 10%.
Laminate
Laminate includes:
I) supporter, which has surface towards skin and opposite surface, and (it means the table away from skin
Face),
Ii) skin contact adhesive, the skin contact adhesive in at least part on the surface towards skin, wherein
Skin contact adhesive has the skin contact surface opposite with the surface towards skin of supporter.
Supporter is the material that can be readily applied to a part of wearer's body.Supporter can be plastic foil, all
Such as polyurethane, polyolefin such as low density polyethylene (LDPE) (LDPE), medium density polyethylene (MDPE), high density polyethylene (HDPE) (HDPE),
Or polypropylene;Polyolefin/polyurethane compound;Polyester;Or ethane-acetic acid ethyenyl ester (EVA).Alternatively, supporter can be paper, knit
Object (woven or nonwoven), silicon rubber or foam.All or part of of supporter optionally has multiple holes (for example, beating
Hole or aperture), to provide gas permeability in laminate.Suitably supporter is known, see, e.g. PCT Publication
WO2013/030580 and WO2014/116281 page 5 to 6.
Skin contact adhesive is located in at least part on the surface towards skin of supporter.For certain applications,
Such as transdermal drug delivery, skin contact adhesive can cover all or most of surface towards skin of supporter, with
Maximize the surface area that drug can be shifted by it.Alternatively, for example, when skin contact adhesive will be used to adhere to absorbing material
When to wound, in a part on the surface towards skin that skin contact adhesive can be located at supporter.Skin on supporter
The amount (thickness) of contact adhesive will depend on various factors and change, these factors include application (for example, fistulization, wound
Nursing and other application may have thicker skin to connect on a support in the application for the strong adhesion strength for needing the long period
Adhesive is touched, but the adhesive for transdermal drug delivery or bandage or medical adhesive tape there can be relatively thin skin on a support
Skin contact adhesive.Thickness can be uniformly.Alternatively, on any given supporter thickness can be it is non-uniform, for example,
It is thicker towards the middle and relatively thin at the edge of supporter or adjacent edges).However, the thickness of skin contact adhesive can
In the range of 0.0635mm to 2.54mm or 0.254mm to 1mm.
Fig. 1 is the partial cross-section of laminate 100 according to the present invention.Laminate 100 includes supporter 101, should
Supporter has the layer of the skin contact adhesive 102 on the surface 104 towards skin of supporter 101.Release liner 103
Cover the surface 105 of the contact skin of the layer of skin contact adhesive 102.Supporter 101 can be for for medical adhesive tape or bonding
The backing of agent bandage or other wound dressings, and as described above.
The layer of skin contact adhesive can be continuous or discontinuous.When discontinuous, which can be various forms,
Such as line, line segment, point or spotwise.Discontinuous form can be in uniform pattern in supporter whole surface, or prop up
Supportting has different pattern at the different zones of object.Fig. 4 shows an example, and the figure shows (do not show for ostomy appliance
Flange 400 in out).Flange 400 has the supporting member 401 for limiting hole 403.Skin contact adhesive 402 as described herein
In the discontinuity layer (being shown as toroid) being formed on supporting member 401.
Laminate also may include one or more layers other layer.For example, laminate may also include iii) release liner,
The skin contact surface of release liner covering skin contact adhesive.Release liner is removable, and can used
It is used during laminate transports and stores before laminate.Bonding can be contacted come exposed skin by removing release liner
Agent.
Suitable release liner includes by polyethylene, polypropylene, fluorocarbon and coated with the peeling paper of fluorosilicone
The liner for being made or coating with the plastic foil for being coated with fluorosilicone.Suitable release liner is known, and in such as PCT
It is described in open WO2007/092350.It is not wishing to be bound by theory, it is believed that prepared by hardening composition as described herein
A benefit of skin contact adhesive be free from fluoride coating (for example, without fluorocarbon and not flucride siloxane)
Release liner can be effectively used together with skin contact adhesive.Release liner with fluoride coating is usually than without fluorination
The release liner of coating is more expensive.Alternatively, release liner includes the liner for being made or being coated by polyethylene or polypropylene.
Laminate optionally also includes iv) absorbed layer.When absorbed layer will directly contact skin (for example, wound),
Such as when laminate is that can will inhale as in Fig. 2 or when Canadian Patent discloses adhesive bandage shown in CA02585933
Receive the skin contact surface that layer is installed to skin contact adhesive.Fig. 2A is shown comprising skin contact adhesive as described herein
The perspective view of the adhesive bandage 200 of 202 thin layer.Fig. 2 B shows the adhesive bandage 200 of the interception of the line A-A in Fig. 2A
Cross-sectional view.Adhesive bandage 200 has the plastic support 204 of punching, and wherein the layer of skin contact adhesive 202 is located at
On the surface 203 towards skin of supporter 204.Absorbed layer 201 is located at the skin contact surface of skin contact adhesive 202
On 205.Alternatively, for example, when skin contact adhesive as described herein is used for such as shown in PCT Publication WO2007/092350
Wound dressing in when, absorbed layer can be between skin contact adhesive and supporter.
Absorbed layer can be any suitable material, can such as absorb the textile fabric or polymer composition (example of fluid
Such as, from the secretion of wound).Absorbed layer can be commercial product, and the example of absorbing polymeric is referring to PCT Publication WO2007/
Page 092350,12 to 15.Example includes but is not limited to: thermoplastic polymer, gathers block copolymer (in addition to ingredient (A))
Alkene, hydrogel and aqueous colloidal.
Laminate also may include v) carrier.Carrier can be used for providing certain rigidity for laminate, and make laminated
Product can be placed on wound in the case where wrinkling minimizes, and avoid laminate being applied to wearer's phase
Between skin contact adhesive itself adhere to.Such as it after laminate is fixed to skin with bonding mode, optionally moves
Except carrier.Carrier is mountable on the opposite surface (it means away from the surface of skin) of supporter.
Carrier can be ethylene vinyl acetate (EVA), polyethylene film, polyester film or the paper coated with EVA coating.This field
It will be recognized that carrier can have and supporter same structure material or different configuration material.As used herein, it carries
Body refers to independent and discrete laminate component.
Fig. 3 is the partial cross-section of substitution laminate 300 according to the present invention.Laminate 300 has supporter
304, the supporter is with the surface 305 towards skin and is intended to away from the opposite surface 303 of skin.Skin contact is bonded
Agent (described herein) 308 is installed to the surface 305 towards skin of supporter 304.Skin contact adhesive 308, which is formed, has skin
The layer of skin contact surface 309.Release liner 310 (there are two parts that can individually remove) covering skin contact adhesive
308 skin contact surface 309.Laminate be also included in supporter 304 surface 305 towards skin and skin contact it is viscous
Absorbed layer 306 between the opposite surface 307 of mixture 308.Laminate also includes carrier 30 as one kind 2, which has towards skin
The surface of skin and opposite surface 301.Carrier 30 as one kind 2 is removably attached to the opposite surface 303 of supporter 304.
The method for being used to prepare laminate
The method for being used to prepare laminate includes:
I the layer of composition described above) is formed in at least part on the surface towards skin of supporter, and
II) hardening composition is to form skin contact adhesive.
This method is optionally further include: III) release liner is applied to it is skin contact adhesive with supporter face
The skin contact surface opposite to the surface of skin.Step III) can be in step II) before or after carry out.This method can also wrap
Include: IV) before hardening in step II), the compressed compositions between supporter and release liner.
It can be by being commonly used in applying a composition to any convenient mode that contact adhesive is applied to substrate
Supporter.Composition can apply for example, by fusion coating, scraper doctor blade technique, solvent cast, blade coating or roller coating.First
It can apply a composition on supporter or release liner.Such as method described in United States Patent (USP) 5,756,572 can be used
Apply a composition to supporter (being taken with composition as described herein for contact adhesive described in bibliography).Alternatively,
Composition can be sandwiched between supporter and release liner, and can apply heat and/or pressure to form laminate, and
And/or person's cross-linked composition is to form skin contact adhesive.Laminate can be prepared as described in WO2015/075448, no
It is with place, replaces polyurethane gle adhesive formulation disclosed in bibliography using composition of the invention.
Prepare the method for laminate optionally further include: III) it sterilizes to laminate.Include skin contact
The laminate of adhesive can be sterilized.Known sterilization method can be used, and (such as, irradiation is (for example, with electron beam or γ spoke
Penetrate) and/or (such as, with xeothermic or steam) is heated to sterilize to laminate.As described above, step III) in go out
Bacterium can be in step I) or step II) carried out later as independent step.Alternatively, sterilizing can be with step I) and/or step II)
It carries out simultaneously.For example, can be heated and/or be irradiated with cross-linked composition, solvent and/or sterilizing are removed.
Using
Skin contact adhesive as described herein is suitable for various applications.The skin contact prepared by cross-linked composition
Adhesive can be used for using such as the adhesive of medical adhesive tape, the adhesive for wound dressing, the bonding for prosthese
Agent, ostomy appliance adhesive, for the adhesive of medical monitor tool, for the adhesive and transdermal of scar therapy treatment
Drug delivery system.
For example, above-mentioned laminate may include supporter and above-mentioned on all or part of surface of supporter
Skin contact adhesive.Skin contact adhesive is formed as continuous or discontinuous layer.In one embodiment, above-mentioned layer
Combination product can be used as adhesive element.Skin contact adhesive can be applied to the surface towards skin of supporter, and
Skin contact adhesive can be used that supporter is adhered to the skin of wearer.For example, above-mentioned skin contact adhesive can be used for
Prosthese, which is adhered to wearer with limbs difference or skin contact adhesive, can be used for adhering to ostomy appliance into tool
Foraminate patient.Ostomy appliance generally includes the pouch for collecting waste, is attached to the flange for limiting hole.Flange exists
There is adhesive, wherein adhesive adheres to the skin of patient with small holes around opening on surface towards skin
(as described in figure 4 above).
Skin contact adhesive as described herein can be used in wound care and fistulization nursing application to adhere to skin,
It can replace contact adhesive disclosed in patent application publication US 2005/0163978, or replace U.S. Patent application public
Open adhesive used in US2014/0323941.
Skin contact adhesive as described herein is suitable for wound dressing.For example, skin contact bonding as described herein
Agent can replace the aqueous colloidal in United States Patent (USP) 5,998,694 to be used as the barrier layer for contacting skin.Skin contact as described herein
Adhesive can be used for PCT Publication WO2007/092350 and patent application publication US 2009/0105670 and US2015/
In 0313593 wound covering object.
Alternatively, skin contact adhesive as described herein can be used for transdermal drug delivery systems.In this embodiment, on
Stating composition includes ingredient (III) active constituent, and also may include (II) excipient.It is not wishing to be bound by theory, it is believed that this
Invention can provide following benefit: cross-linked composition can not adversely influence (III) active constituent to form skin contact adhesive.
Skin contact adhesive of the invention can be used for such as United States Patent (USP) 4,840,796 and 4,951,657 and U.S. Patent application
In transdermal drug delivery systems described in open US2005/0048104 and US2007/0172518.
Coating composition
Above-mentioned copolymer compositions can or be used in coating composition, and the coating composition is for example in substrate
Form coating.Coating composition includes: (a) above-mentioned copolymer compositions;And (b) coating additive.Coating additive is optional
From (b1) water scavenger, (b2) pigment, (b3) diluent, (b4) filler, (b5) antirust agent, (b6) plasticizer, (b7) thickening
Agent, (b8) pigment dispersing agent, (b9) flow aid, (b10) solvent, (b11) adhesion promoter, (b12) catalyst, (b13)
Having machine aided binder, (b14) siloxanes to help, binder, (b15) delustering agent, (b16) levelling agent, (b17) wax, (b18) is quenched adds
Add agent, (b19) anti-scratch additive, (b20) gloss modified additive, (b21) stabilizer and (b22) crosslinking agent, or (b1),
(b2)、(b3)、(b4)、(b5)、(b6)、(b7)、(b8)、(b9)、(b10)、(b11)、(b12)(b13)、(b14)、(b15)、
(b16), combination two or more in (b17), (b18), (b19), (b20), (b21) and (b22).Suitable filler packet
Include silica and titanium dioxide or zirconium dioxide.Suitable adhesion promoter includes alkoxy silane, such as 3- glycidol
Oxygroup propyl trimethoxy silicane.Suitable solvent as prepared described in the method for copolymer above.Suitably (b2) pigment,
(b3) diluent, (b4) filler, (b5) antirust agent, (b6) plasticizer, (b7) thickener, (b8) pigment dispersing agent, (b9) stream
The example of dynamic property auxiliary agent, (b10) solvent and (b11) adhesion promoter is disclosed in U.S. Patent Application Publication No. 2015/0031797
In PCT Publication WO2015/097064, WO2015/100258 and WO2016/126362.Based on being used to prepare coating composition
All initial substances combination weight, in the coating composition as initial substance (b12) catalyst can with it is described above
Initial substance e) it is identical, and can be present in coating composition with the amount of 0.01 weight % to 5.00 weight %.Starting material
Matter (b13) is to have machine aided binder, such as polyalcohol, polyamine or polyisocyanates;Based on the institute for being used to prepare coating composition
There is the combination weight of initial substance, which can be added in coating composition with 0% to 99% amount.Initial substance
(b14) binder is helped for siloxanes, based on the combination weight of initial substances all in coating composition, which helps binder
It can be added with 0% to 99% amount.Initial substance (b15) is delustering agent, the group based on initial substances all in coating composition
Weight is closed, which can be 0% to 30%.Initial substance (b16) is levelling agent, and the levelling agent is with the 0% of coating composition
To 10% presence.Initial substance (b17) is wax, which can account for the 0% to 20% of coating composition described herein.Initial substance
(b18) it is flocking additive, can be added in coating composition with 0% to 20% amount.Based on all in coating composition
The total weight of initial substance, initial substance (b19), (b20), (b21) and (b22) combination can be 0% to 15%.
Hardenable coating composition is to be formed on the substrate coating, such as priming paint or Topcoating.Substrate can be metal, glass
Glass, timber, the coat of paint, plastic foil, fiber and/or textile fabric or leather.It can exist during preparing fiber or textile fabric, or then
Coating composition is applied to substrate (for example, fiber and/or textile fabric) during such as washing textile fabric.It, can be with after application
Such as by under environment temperature or raised temperature dry paint composition by solvent (if any) from Coating material composition
It is removed in object.Dry weight based on substrate, the amount for being applied to the treatment compositions of substrate (for example, fiber and textile fabric) are typically enough to
The composition of 0.1 weight % to 15 weight %, or the dry weight based on substrate are provided in substrate, are 0.2 weight % to 5 weights
Measure the amount of %.
The fiber and textile fabric of available processes compositions-treated include natural fiber, such as cotton, silk, linen and sheep
Hair;Regenerated fiber, such as artificial silk and acetic acid esters;Synthetic fibers, such as polyester, polyamide, polyacrylonitrile, polyethylene and poly- third
Alkene;Their combination and blend.The form of fiber may include line, long filament, tow, yarn, Woven fabric, woven materials, non-
Weaving material, paper and carpet.For the purpose of present patent application, other base can be handled with treatment compositions (including leather)
Bottom.It is not wishing to be bound by theory, it is believed that have and conventional hydrophobic siloxanes with the textile fabric that silicone block copolymer is handled
Comparable feel, but not apparent adverse effect is generated to the hydrophily of textile fabric.It is not wishing to be bound by theory, it is believed that by upper
The coating for stating coating composition formation can have one of following benefit or a variety of: high glaze, flexibility, hardness, scratch-resistant
Property and weatherability, ultraviolet light resistant it is exposed or two or more in them.
Embodiment
It now will some embodiments of detailed description of the present invention in the examples below.It is not existing skill referring to embodiment
Art, except where so indicated.
Table A-abbreviation
Reference example-is used to prepare the general procedure of copolymer
500ml four-neck flask is placed in temperature control heating block, and loads onto mechanical agitator, thermometer, dropping funel and returns
Flow condenser.
1) a) isocyanate compound and b) polysiloxane are added into flask, are mixed to form mixture.
2) stir mixture and at 70 DEG C heat a period of time, then add solvent and the reaction is cooled to 40 DEG C with
Under.
3) remaining isocyanate compound is added.
4) by c) chain extender and (optionally) d) crosslinking agent is added in dropping funel together with other solvent, and dropwise
It is added in the mixture in flask, a period of time is then heated at 70 DEG C.
5) mixture in flask is cooled to room temperature, and is poured into the deionized water of 2 liters (L).With other
The copolymer of water washing precipitating, is collected and is placed in vacuum drying oven, and dry 24 under 75 DEG C and 50 millibars (mbar)
Hour.
Sample is prepared using initial substance shown in table 1 and condition according to the program.
The preparation of table 1- copolymer
Table 2 shows the NMR result of the embodiment in table 1 and the molecular weight (Mw) (if applicable) of GPC measurement.Into
Row1H-NMR analysis (in terms of ppm, solvent C DCl3) analysis.GPC condition: the THF (1.0ml/min) at 35 DEG C;Column: polymer is real
Test 5 μm of mixing-C columns of room PLgel;Detector: 2410 differential refractometer of Waters.
Table 2- copolymer characterization result
Embodiment 1: it is used to prepare the DMS-C16-PU32 copolymer (20% hard segment contents) of adhesion strength test sample Preparation。
The copolymer of entitled DMS-C16-PU32 of 5gm is weighed into bottle, and adds the acetic acid second of 5 grams (gm)
Ester.Then, the substance is mixed, until all copolymers are dissolved in ethyl acetate, and obtains clear solution.Then, using 20
The mixture is coated to Mylar on piece by the drawdown rod of mil.According to standard pressure sensitive adhesive (PSA) program, lamilate is obtained.
Due to all copolymers be 50% ethyl acetate in solution, first at room temperature in vent cabinet in vaporizing coating material
Solvent, and it is then in ventilated drying oven that coating is 5 minutes dry at 95 DEG C.It is further covered with LDPE release liner laminated
Body, and stand overnight at room temperature.Then the adhesion strength, fissility and cohesive strength of each sample are tested.
When carrying out removing measurement, release liner is fixed in bottom jig, and be coated with the layer of polyurethane of adhesive
Zoarium is fixed in top clamp.Fixture is pulled open into 130mm with 10mm/s.The value of each test of report is from coated with bonding
Mean force (N)/in of release liner is pulled in the polyurethane laminates of agent.The data from preceding 20mm and last 10mm are abandoned,
And the data of remaining 100mm are averaged.Test one to three is measured in parallel to generate report value, and final measurement unit is ox
/ (linear) inch (N/in).The value of Final Report is the average value (1 inch=~25mm) of 1 to 3 test-strips.
Adhesion strength is measured, release liner is removed from lamilate, wherein lamilate adheres to 1.5in × 9in
On the frosted side of (3.8cm × 23cm) polycarbonate item.Using the roller for being coated with 5 pounds of (lb) rubber, by lamilate with 1in/ seconds
The rate of (2.5cm/ seconds) is applied on polycarbonate to previous stroke and to the latter stroke.Allow sample and polycarbonate
It is kept in contact 30 minutes.Dduring test, polycarbonate is fixed in bottom jig, while lamilate is fixed on top folder
In tool.With in peel test, fixture is pulled open into 130mm with 10mm/s.Lamilate (1in wide) is led from polycarbonate
The power of drawing is average on 100mm (the preceding 20mm and last 10mm that exclude 130mm drawing), and final measurement unit is newton/(line
Property) inch (N/in).The value of Final Report is the average value of 1 to 3 test.
Estimate the amount of the adhesive remained on polycarbonate after testing adhesion strength by visual observation to assess cohesional failure
Percentage.In the conceived case, by by adhesive cohesion failure (real cohesional failure) with from polyurethane bottom
It is distinguished between the transfer (adhesion failures of bases) of polycarbonate.Any adhesive, which remains on polycarbonate, to be claimed
To indicate cohesional failure.These adhesion strength test results are included in table 3.
The preparation of embodiment 2:DMS-C16-PU33 copolymer (20% hard segment contents)
The copolymer of entitled DMS-C16-PU32 (5gm) is weighed into vial, and adds 5gm ethyl acetate.So
Afterwards, the content in bottle is mixed on turbine mixer, until all copolymers are dissolved in ethyl acetate, and is clarified
Solution.Laminate is prepared, and assesses its adhesion strength, fissility and cohesive strength as in Example 1.
The preparation of embodiment 3:DMS-C16-PU34 copolymer (17.5% hard content)
The DMS-C16-PU34 of 5gm is weighed into vial, and adds 5gm ethyl acetate.Then, in turbine mixer
Upper mixing substance until all copolymers are dissolved in ethyl acetate, and obtains clear solution.System as in Example 1
Standby and test laminate.
The preparation of embodiment 4:DMS-C16-PU39 copolymer (17.5% hard content)
The DMS-C16-PU39 of 5gm is weighed into vial, and adds 5gm ethyl acetate.Then, in turbine mixer
Upper mixing substance until all copolymers are dissolved in ethyl acetate, and obtains clear solution.System as in Example 1
Standby and test laminate.
The preparation of embodiment 5:DMS-C16-PU40 copolymer (17.5% hard content)
The DMS-C16-PU40 of 5gm is weighed into vial, and adds 5gm ethyl acetate.Then, in turbine mixer
Upper mixing substance until all copolymers are dissolved in ethyl acetate, and obtains clear solution.System as in Example 1
Standby and test laminate.
Embodiment 6:DMS-C16-PU23 (36.5% hard content) and DMS-C16-PU33 (20% hard content) are total to
Mix formulation
Weigh the 50%DMS-C16-PU23 ethyl acetate solution of the 3gm prepared as described above and the 50%DMS- of 1.5gm
C16-PU33 ethyl acetate solution is into vial.Then every kind of solution is mixed on turbine mixer, until being clarified
Solution.Then with different ratio mixed solutions as shown in table 4.Preparation and test laminate as in Example 1.
Using the ratio of hard content and soft content in identical copolymer but change preparation, to prepare a series of preparations.By institute
There is preparation to be transferred in lamilate, and tests its adhesion strength, fissility and cohesive strength according to the program in embodiment 1.
Table 3: the result of embodiment 1 to 5
Table 4: the result of embodiment 6
The synthesis of embodiment 7- copolymer
Siloxanes-carbamate-urea copolymer sample shown in following table 5 by measuring methanol functionalized poly two
Methylsiloxane (C62) is combined with isophorone diisocyanate to prepare.Optionally poly- second of the addition with different molecular weight
Glycol (PEG600 and PEG1500).It combines above-mentioned initial substance in flask with methyl isobutyl ketone solvent, and under stiring
It is heated to 60 DEG C.Then catalyst (bismuth neodecanoate) is added.Temperature is increased into 80C, and flask contents are heated at 80C
2 hours.Isocyanate content is measured via titration according to DIN EN ISO 11909.
PPG 400 is polypropylene glycol.All organic-the silicone copolymers prepared in embodiment 7 are the clarification in MEK
And uniform solution.It is horizontal that remaining NCO is measured according to calculated value.
Embodiment 9- coating
The copolymer prepared in embodiment 7 is prepared in the coating composition, is then hardened with prepares coating.Coating
Composition contains the initial substance of amount shown in the following table 6.Coating composition is prepared by mechanical blending initial substance.
Table 6- coating composition
By the coating composition in table 6 on aluminium Q- plate Q36.Film thickness is 100 microns (μm).Before test,
By exposing solidification composition filling over 7 days at ambient conditions.Each coating in substrate has smooth and uniform surface.
Contrast sample (" 0 ") is prepared by composition shown in mechanical blending the following table 7.In addition, preparation completely has
Machine coating composition, which is used as, refers to (" 00 ").
Table 7- compares coating composition
Composition in table 7 is applied in substrate, and progress as described in above with respect to the composition in table 6
Solidification.Coating composition " 00 " generates transparent and uniform film.Coating " 0 " generates liquid composition heterogeneous, and is applying
In addition after, the film surface with many pin holes and pit is formed.This method shows using containing polyurethane-poly organo
The composition of alkyl copolymer allows improved coating to be formed, and allows sensitively to enhance siloxanes in these compositions special
Property.
Table 8 shows the durability test result of the coating of the composition in table 6.
The test result of coating in 8. table 6 of table。
Table 8 is shown, and the repellency with the coating of organic-silicone copolymers preparation as described herein is quicker than organic system
Feel higher.Since siloxane unit is chemical bonding, therefore, it is considered that not will do it any flushing in layer aging period.Show that layer has compared with high-flexibility with Clemen value, therefore has during handling paint and during coating aging
Lower cracking risk.Clemen test is to measure coating using the tungsten needle being applied on coating under the pressure being increasing
Hardness.Rise instruction electrical strength destruction, this again indication coating destruction.This method is ISO 1518.It is applied using being deposited on
Water droplet on layer, and using the camera measurement equipped with digital goniometer, to measure water contact angle.It is recorded at T0 and T30
Angle.This meets DIN standard: DIN 55660-2.
It is not wishing to be bound by theory, it is believed that, one or more of following benefit will be presented in the coating prepared as described above:
It is improved compatibility, improved weatherability, hydrophobicity, hydrolytic stability, radiation resistance between polyurethane and siloxanes, resistance to
Hot, corrosion resistance, surface smoothness and gloss, scratch resistance, the relatively low viscosity under similar solid content (influence volatility
Content of organics, VOC) and friction reduction, and if be bonded based on the substance of siloxanes with carbamate backbone chemical
(such as in copolymer described herein), instead of by siloxanes mechanical dispersion carbamate in the coating, these benefits
It will be more longlasting.
Claims (15)
1. a kind of copolymer compositions, the copolymer compositions include: two or more initial substances, wherein
(I) at least one of described initial substance be copolymer (A) or copolymer (B), wherein
Copolymer (A) is following modular siloxanes-carbamate-urea copolymer:
Wherein
Each RDIt independently is divalent hydrocarbyl mission, divalent halogenated hydrocarbon group;
Each RMIt independently is monovalent hydrocarbon radical or monovalence halogenated hydrocarbon group;
Each RTIt independently is hydrogen or hydrocarbyl group;
Each subscript b is independently 0 to 1,000,000;
Subscript c is 0 to 200,000, and subscript i is 0 to 200,000, and subscript w1 is 0 to 200,000, and subscript w2 is 0 to 200,
000, subscript w3 are 0 to 200,000, and subscript w4 is 0 to 200,000, and quantity (c+i+w1+w2+w3+w4) >=1;
Subscript d is 0 to 1,000,000;
Subscript e is 0 to 1,000,000;
Subscript f is 0 to 1,500,000;
Subscript h >=0;
Subscript j1 >=0;
Each X independently is nitrogen, oxygen or sulphur;
When X is oxygen or sulphur, subscript o=0, and when X is nitrogen, subscript o=1;
Subscript r is 0 to 1,500,000, and quantity f+r >=1;
Subscript s is 0 to 200,000;And
Subscript v is 0 to 200,000;
Subscript y >=0;
And
Copolymer (B) is siloxanes-carbamate-urea copolymer of following formula:
Wherein all symbols and under be marked on A) in defined, and subscript j2 > 0, and if j1 > 0, j2/
j1≥1.1;And
(II) optionally one or both of initial substance (C) and (D), wherein
It (C) is organic polyhydric alcohol;And
It (D) is the reaction product of organic multiple isocyanate and organic polyhydric alcohol.
2. composition according to claim 1, wherein at least two initial substance is selected from:
(A) and (B);
(A) and (C);
(B) and (C);
(A) and (D);
(B) and (D);
(A), (B) and (C);
(A), (B) and (D);
(A), (C) and (D);
(B), (C) and (D);Or
(A), (B), (C) and (D).
3. according to claim 1 or composition as claimed in claim 2, also including (E) organic siloxane polymer.
4. composition according to any one of the preceding claims, wherein there are copolymer (A), and copolymer (A) wraps
Formula (I) containing unit:
Wherein each subscript a is independently 0 to 1,000,000;Each subscript b is independently greater than or is equal to 0;Each subscript m >=
0, and subscript n is greater than or equal to 1.
5. composition according to any one of the preceding claims, wherein there are copolymer (B), and copolymer (B) wraps
Formula (III) containing unit:
,
Wherein subscript n is greater than or equal to 1, and subscript n 1 is greater than or equal to 0, and subscript n 2 and n3 are 0 or 1, and quantity (n2+n3)=
1。
6. a kind of skin contact adhesive composition, the skin contact adhesive composition includes:
(I) copolymer compositions according to any one of the preceding claims, and
(II) excipient, and
Optionally (III) active constituent.
7. skin contact adhesive composition according to claim 6, wherein the excipient be selected from (II-1) stabilizer,
(II-2) binder, (II-3) filler, (II-4) solubilizer, (II-5) skin penetration enhancer, (II-6) adhesion promoter,
(II-7) improve two in the reagent or (II-1), (II-2), (II-3), (II-4), (II-5), (II-6) and (II-7) of penetrability
The combination of kind or more.
8. according to claim 6 or skin contact adhesive composition as claimed in claim 7, wherein there is (III) described work
Property ingredient, and the active constituent is selected from and acts on the drug of central nervous system;Influence the drug of renal function;Influence painstaking effort
The drug of pipe function;Influence the drug of gastrointestinal function;For treating the drug of vermination;Antimicrobial, such as silver, patina are closed
Object and/or Chlorhexidine;Nutriment;Hormone;Steroids;And for treating dermopathic drug;Non-steroidal anti-inflammatory drugs, such as
Salicylate, such as acetylsalicylic acid;Propanoic derivatives, such as (RS) -2- (4- (2- methyl-propyl) phenyl) propionic acid (Bu Luo
It is fragrant);Acetogenin, such as 2- { 1- [(4- chlorphenyl) carbonyl] -5- methoxyl group -2- Methyl-1H-indole -3- base } acetic acid (Yin
Diindyl U.S. is pungent), enolic acid derivative;Anthranilic acid derivative, cox 2 inhibitor, for example, N- (4- hydroxy phenyl) acetamide
N- (4- hydroxy phenyl) acetamide (paracetamol) and sulfonanilide;Local anesthetic, such as containing the part of ester group
Anesthetic, for example, 4-aminobenzoic acid ethyl ester (benzocainum);Local anesthetic containing amide group, for example, 2- (diethyl
Amino)-N- (2,6- 3,5-dimethylphenyl) acetamide (lidocaine);And natural local anesthetic, such as (1R, 2S,
5R) -2- isopropyl -5- methyl cyclohexanol (menthol).
9. skin contact adhesive composition according to claim 8, wherein the active constituent be selected from antimicrobial,
Non-steroidal anti-inflammatory drugs and local anesthetic.
10. use of the skin contact adhesive according to any one of claims 6 to 9 in the application selected from the following terms
On the way: the adhesive for medical adhesive tape, the adhesive for wound dressing, the adhesive for prosthese, ostomy appliance bonding
Agent, for medical monitor tool adhesive, for scar therapy treatment adhesive, for cosmetics drug paste adhesive with
And transdermal drug delivery systems.
11. according to claim 8 or skin contact adhesive as claimed in claim 9 in the application of cosmetics drug paste, scar therapy
Using or transdermal drug delivery application in purposes.
12. a kind of coating composition, the coating composition includes:
(a) copolymer compositions according to any one of claim 1 to 5,
(b) coating additive.
13. coating composition according to claim 12, wherein (b) coating additive be selected from (b1) water scavenger,
(b2) pigment, (b3) diluent, (b4) filler, (b5) antirust agent, (b6) plasticizer, (b7) thickener, the dispersion of (b8) pigment
Agent, (b9) flow aid, (b10) solvent, (b11) adhesion promoter, (b12) catalyst, (b13) have machine aided binder,
(b14) siloxanes helps binder, (b15) delustering agent, (b16) levelling agent, (b17) wax, (b18) quenched additive, (b19) anti-scratch
Wipe additive, (b20) gloss modified additive, (b21) stabilizer and (b22) crosslinking agent, or (b1), (b2), (b3),
(b4)、(b5)、(b6)、(b7)、(b8)、(b9)、(b10)、(b11)、(b12)(b13)、(b14)、(b15)、(b16)、(b17)、
(b18), combination two or more in (b19), (b20), (b21) and (b22).
14. a kind of method, which comprises
I) coating composition described according to claim 12 or claim 13 is applied to substrate, and
Ii the composition is hardened) to form coating.
15. according to the method for claim 14, wherein the substrate includes leather.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662396336P | 2016-09-19 | 2016-09-19 | |
US62/396336 | 2016-09-19 | ||
PCT/US2017/047468 WO2018052646A1 (en) | 2016-09-19 | 2017-08-18 | Copolymer composition for coating and adhesive applications |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109843380A true CN109843380A (en) | 2019-06-04 |
CN109843380B CN109843380B (en) | 2021-08-17 |
Family
ID=59895358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780064745.6A Active CN109843380B (en) | 2016-09-19 | 2017-08-18 | Copolymer compositions for coating and adhesive applications |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210284840A1 (en) |
EP (1) | EP3515560A1 (en) |
JP (1) | JP6901552B2 (en) |
KR (1) | KR102193820B1 (en) |
CN (1) | CN109843380B (en) |
WO (1) | WO2018052646A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111388355A (en) * | 2020-04-06 | 2020-07-10 | 华中科技大学同济医学院附属协和医院 | Skin protective agent for preventing pathogen contact and preparation method thereof |
CN113026198A (en) * | 2019-12-09 | 2021-06-25 | 中昊晨光化工研究院有限公司 | Functional dressing and preparation method thereof |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD848624S1 (en) * | 2016-09-29 | 2019-05-14 | Ethicon, Inc. | Release paper for wound treatment devices |
CN113518813B (en) * | 2019-02-28 | 2022-10-25 | Agc株式会社 | Urethane prepolymer, adhesive, attachment material, adhesive tape, wearable device, and wearable device kit |
US20230332013A1 (en) * | 2020-09-11 | 2023-10-19 | Dow Silicones Corporation | Isocyanate-functional prepolymer, composition comprising same, and coating formed therewith |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4840796A (en) * | 1988-04-22 | 1989-06-20 | Dow Corning Corporation | Block copolymer matrix for transdermal drug release |
EP0338820A2 (en) * | 1988-04-22 | 1989-10-25 | Dow Corning Corporation | Heat sealable membrane for transdermal drug release |
JPH04292676A (en) * | 1991-03-20 | 1992-10-16 | Toyoda Gosei Co Ltd | Coating composition |
US5756572A (en) * | 1995-07-24 | 1998-05-26 | Dow Corning Corporation | Silicone pressure sensitive adhesive composition containing thermoplastic multi-segmented copolymer |
WO2004055088A1 (en) * | 2002-12-17 | 2004-07-01 | Basf Aktiengesellschaft | Polyether urethane containing allyl groups |
US20040254325A1 (en) * | 2003-06-12 | 2004-12-16 | Wacker-Chemie Gmbh | Organopolysiloxane/polyurea/polyurethane block copolymers |
US20070071700A1 (en) * | 2005-09-23 | 2007-03-29 | Anjali Abhimanyu Patil | Cosmetic compositions containing silicone/organic copolymers |
DE102006056379A1 (en) * | 2006-11-29 | 2008-06-05 | Wacker Chemie Ag | Siloxane-urea copolymers |
CN101321558A (en) * | 2005-12-30 | 2008-12-10 | 雅芳产品公司 | Long wearing cosmetic compositions |
EP1588686B1 (en) * | 2004-04-23 | 2010-08-18 | Intercos S.p.A. | Cosmetic compositions and their use |
CN102803423A (en) * | 2009-04-17 | 2012-11-28 | 3M创新有限公司 | Silicone gel adhesive construction |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3384623A (en) | 1964-01-11 | 1968-05-21 | Toyo Spinning Co Ltd | Production of polyurethane elastomers |
DE4121785A1 (en) | 1991-07-02 | 1993-01-07 | Bayer Ag | METHOD FOR PRODUCING THERMOPLASTIC POLYURETHANE ELASTOMERS |
US5998694A (en) | 1994-03-02 | 1999-12-07 | Jensen; Ole R. | Occlusive dressing with release sheet having extended tabs |
DE4437586A1 (en) | 1994-10-20 | 1996-04-25 | Basf Schwarzheide Gmbh | Process for the preparation of thermoplastic polyurethanes |
US6528121B2 (en) | 1998-11-19 | 2003-03-04 | Dow Corning Toray Silicone Co., Ltd. | Aqueous treatment agent for wiping paper |
KR100622332B1 (en) | 1999-04-01 | 2006-09-13 | 알자 코포레이션 | Transdermal drug delivery devices comprising a polyurethane drug reservoir |
CN100556929C (en) | 2003-10-10 | 2009-11-04 | 陶氏康宁公司 | The polyurethane composition that contains the silicone resin of carbinol-functional |
US20050163978A1 (en) | 2004-01-27 | 2005-07-28 | Esben Strobech | Article having a surface showing adhesive properties |
JP5160217B2 (en) | 2004-03-12 | 2013-03-13 | ダウ・コーニング・コーポレイション | Method for preparing a silicone pressure sensitive adhesive for supplying hydrophilic drugs using a silicone polyether |
WO2007092350A1 (en) | 2006-02-02 | 2007-08-16 | H.B. Fuller Licensing & Financing, Inc. | Wound care articles, drug delivery systems and methods of using the same |
BRPI0601479A (en) | 2006-05-03 | 2007-12-18 | Johnson & Johnson Ind Ltda | adhesive bandage |
WO2008088491A2 (en) | 2006-12-20 | 2008-07-24 | Dow Corning Corporation | Silicone resin coating compositions containing blocked isocyanates |
JP2011500272A (en) | 2007-10-23 | 2011-01-06 | ボリンジャー・テクノロジーズ・エル・ピー | Thin film wound covering, suction wound treatment system using thin film wound covering, method of using thin film wound covering, and method of manufacturing thin film wound covering |
GB201115182D0 (en) | 2011-09-02 | 2011-10-19 | Trio Healthcare Ltd | Skin contact material |
JP2013133408A (en) | 2011-12-27 | 2013-07-08 | Dow Corning Toray Co Ltd | Ordinary temperature-curable coating composition |
WO2014116281A1 (en) | 2013-01-25 | 2014-07-31 | Patenaude Bart | Atraumatic wound care and closure system |
GB201320432D0 (en) | 2013-11-19 | 2014-01-01 | Scapa Uk Ltd | Novel formulation |
WO2015100258A1 (en) | 2013-12-23 | 2015-07-02 | Dow Corning Corporation | Uv-curable silicone compositions and anti-dust coating compositions containing same |
GB201323041D0 (en) | 2013-12-23 | 2014-02-12 | Dow Corning | Curable coating compositions containing an unsaturated alkoxysilane |
TWI707932B (en) | 2015-02-03 | 2020-10-21 | 美商道康寧公司 | Hardcoat and related compositions, methods, and articles |
-
2017
- 2017-08-18 US US16/334,562 patent/US20210284840A1/en not_active Abandoned
- 2017-08-18 JP JP2019513882A patent/JP6901552B2/en active Active
- 2017-08-18 WO PCT/US2017/047468 patent/WO2018052646A1/en unknown
- 2017-08-18 EP EP17768537.7A patent/EP3515560A1/en not_active Withdrawn
- 2017-08-18 KR KR1020197009464A patent/KR102193820B1/en active IP Right Grant
- 2017-08-18 CN CN201780064745.6A patent/CN109843380B/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4840796A (en) * | 1988-04-22 | 1989-06-20 | Dow Corning Corporation | Block copolymer matrix for transdermal drug release |
EP0338820A2 (en) * | 1988-04-22 | 1989-10-25 | Dow Corning Corporation | Heat sealable membrane for transdermal drug release |
JPH04292676A (en) * | 1991-03-20 | 1992-10-16 | Toyoda Gosei Co Ltd | Coating composition |
US5756572A (en) * | 1995-07-24 | 1998-05-26 | Dow Corning Corporation | Silicone pressure sensitive adhesive composition containing thermoplastic multi-segmented copolymer |
WO2004055088A1 (en) * | 2002-12-17 | 2004-07-01 | Basf Aktiengesellschaft | Polyether urethane containing allyl groups |
US20040254325A1 (en) * | 2003-06-12 | 2004-12-16 | Wacker-Chemie Gmbh | Organopolysiloxane/polyurea/polyurethane block copolymers |
EP1588686B1 (en) * | 2004-04-23 | 2010-08-18 | Intercos S.p.A. | Cosmetic compositions and their use |
US20070071700A1 (en) * | 2005-09-23 | 2007-03-29 | Anjali Abhimanyu Patil | Cosmetic compositions containing silicone/organic copolymers |
CN101321558A (en) * | 2005-12-30 | 2008-12-10 | 雅芳产品公司 | Long wearing cosmetic compositions |
DE102006056379A1 (en) * | 2006-11-29 | 2008-06-05 | Wacker Chemie Ag | Siloxane-urea copolymers |
CN102803423A (en) * | 2009-04-17 | 2012-11-28 | 3M创新有限公司 | Silicone gel adhesive construction |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113026198A (en) * | 2019-12-09 | 2021-06-25 | 中昊晨光化工研究院有限公司 | Functional dressing and preparation method thereof |
CN111388355A (en) * | 2020-04-06 | 2020-07-10 | 华中科技大学同济医学院附属协和医院 | Skin protective agent for preventing pathogen contact and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
EP3515560A1 (en) | 2019-07-31 |
JP6901552B2 (en) | 2021-07-14 |
WO2018052646A1 (en) | 2018-03-22 |
US20210284840A1 (en) | 2021-09-16 |
CN109843380B (en) | 2021-08-17 |
KR20190047716A (en) | 2019-05-08 |
KR102193820B1 (en) | 2020-12-24 |
JP2019531795A (en) | 2019-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109843380A (en) | The copolymer compositions applied for coating and adhesive | |
EP3114151B1 (en) | Low cytotoxicity switchable adhesive compositions, medical dressings and skin coverings, and methods of treatment using same | |
US9399123B2 (en) | Silicone adhesive compositions | |
US9017771B2 (en) | Gentle to skin adhesive | |
CN107429029A (en) | Removable film forming gel composition and its application process | |
JP6141868B2 (en) | Adhesive article and manufacturing method thereof | |
WO2018052645A1 (en) | Skin contact adhesive and methods for its preparation and use | |
JP2007532179A (en) | Silicone skin adhesive gel | |
CN105007954B (en) | Silicone film | |
CN115666666A (en) | Novel antimicrobial topical skin closure compositions and systems | |
CN109715692A (en) | Skin contact adhesive and its preparation and application | |
TW202017754A (en) | Stretchable film and method for forming stretchable film | |
CN109890864A (en) | Polyurethane-polyorganosiloxane copolymer and the method prepared for it | |
JP7135782B2 (en) | Medical adhesive composition and medical adhesive sheet | |
CN109337492A (en) | Hydrophilic superslide coating and exempt from activate coating catheter | |
JP2001253819A (en) | Adhesive tape for medical use | |
CA3230379A1 (en) | Patch | |
JP2023142406A (en) | Adhesive composition for skin patch, hardened material thereof and adhesive tape for skin patch |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |